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ABSTRACT 
Investigations into the mediators of effort sensation have indicated that central mechanisms 
related to corollary discharges may be responsible fbr an increased sense of effort during 
fatiguing isometric exercise. The role for central mediators for sense of effort have been 
objectively demonstrated through use of contralateral limb matching tasks. Subjects 
diagnosed with chronic fatigue syndrome (CFS) often report prevalent fatigue associated 
with a greater sense of effort when involved in exercise. This study employed a fatiguing 
contralateral limb-matching task in order to determine if CFS subjects (n == 6) experienced 
an altered sense of effort associated with the task when compared to control group (n = 6). 
The task involved subjects performing an intennittent sub-maximal contraction in their 
reference (non-dominant) arm for a 45 minute period. Subjects attempted to match the 
force in their reference arm (30% lviVC) with their dominant ann every minute, except for 
every fifth minute, when a maximal voluntary contraction (MVC) was performed in the 
reference arm. Associated electromyography (EMG), force, and rate of perceived exertion 
(RPE) were recorded on a regular basis. Results indicated that while there were no 
significant diffurence between groups for matching force, nnsEMG amplitude, and MVC 
force, there was a significant difference in reported RPE scores (P < 0.05) during the 
fatiguing task, as well as during baseline measurements. Elevated RPE scores, combined 
with trends indicating that a longer protocol may have produced a significant difference in 
matching force, provide evidence demonstrating thdt CFS subjects experienced a greater 
sense of effort relative to controls. This study demonstrates that the symptom of fatigue 
experienced in CFS may be better defined employing mediators for sense of effort than the 
regular application of a neurophysiological definition of fatigue concerned with the loss of 
force generating capacity. 
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CHAPTER ONE 
INTROnUCTION 
1.1 Background To Study 
Most of us at some time or another have been involved in an activity and experienced an 
increasing sense of effort as time passes. The child we are holding begins to feel like a 
dead weight; the brief case could serve as an anchor; while the five-kilometre jog, which 
began with a spring in the step ends with legs that feel like lead, coupled with a respiration 
rate that alarms onlookers. It is on the basis of these feelings that decisions are made as to 
whether or not the activity will continue at the same pace, slow down or even come to an 
abrupt halt. The ability to sustain a desired pace or even to continue an activity is crucial 
for the competitive athlete. For the sports scientist and clinician, an understanding of the 
factors that constitute this sense of effort will assist in the designing of effective exercise 
and rehabilitation programs. 
Study of the primary mediators in effort sensation is particularly pertinent to those people 
who suffer from 'effort syndromes' such as chronic fatigue syndrome (CFS). CFS 
represents a debilitating disorder that is characterised by severe mental and physical fatigue 
(Edwards, 1992). Often the fatigue reported by people with CFS is associated with an 
increased sense of effort when perfonning exercise and everyday tasks (Lawrie, McHale, 
Power & Goodwin, 1997). Application of a neurophysiological definition to the term 
fatigue (i.e. loss of force generating capacity), has allowed investigators to explore the 
symptom of fatigue reported by CFS subjects from a peripheral and/or central perspective. 
While results have been equivocal, the majority of studies have demonstrated nonna\ 
muscle physiology in CFS subjects, implying a central basis for fatigue (Jamel & Miller, 
1991; Lloyd, Gandevia & llales, 1991; Wessely & Edwards, 1993). 
Further research into the symptom of fatigue experienced by people with CFS is provided 
by mediators that contribute to sense of effort. According to McCloskey ( 1978), Jones and 
Hunter ( 1983a), and Cafarelli (1988), employment of a contralateral limb mat<hing ta>k 
during a t8.tiguing exercise, provides objective measurement of sense of effort. This task 
demonstrates that as fatigue develops, attempts to match a low-level isometric force held in 
the reference limb tend to be overestimated by the contralateral limb. Overestimation of the 
reference force indicates attention to central mediators for effort sense rather than the actual 
force (Jones, 1995). Employment of a contralateral limb matching paradigm during a 
fatiguing, sub-maximal, isometric task is ideall) · suited for investigating whether CFS 
tmbjects associate a given task with a greater sense of effort, when compared to healthy 
controls. If CPS subjects consequently report a greater 'lense of effort. then this may imply 
a relationship between the fatigue experienced by people with CFS and central mediators 
for sense of effort. 
CFS represents a debilitating disorder that is poorly understood. Currently there is a lack of 
consensus regarding the basis of the fatigue symptoms that typifY the disorder, while 
controversy surrounds the aetiology of the disease. Investigation into the sense of effort 
experienced by CFS sufferers may lead to a better understanding of the disorder, as well as 
provide the basis for a quantitative measure for the perception of thtigue. This would be 
useful in assessing the severity of the condition, as well as for monitoring progress over 
time. 
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1.2 I'U!JlOSC of Study 
The purpose of this study is to determine whether an cxcrctsc paradigm consisting of 
intcm1ittcnt sub-maximal and maximal isometric contractions of the elbow flexors is 
associated with an abnomtal strength decline and a greater sense of effort in CFS subjects, 
when compared to healthy control subjects. This will assist in detennining whether altered 
muscle function and/or an altered sense of effort play a role in the poor exercise tolerance 
displayed by CFS subjects. 
1.3 Aims of Study 
The aims of this study are: 
I To determine whether CFS subjects have a percentage strength loss similar to 
controls when perfonning intennittent MVC during a fatiguing task. 
2 To determine whether CFS subjects have an altered sense of effort associated with a 
f"tiguing task. 
3 
I.
1.4 Research Questions 
This study addresses the following research questions: 
Will CFS subjects show the same decline in maximum force during a fatiguing 
exercise, when compared to control subjects'? 
2 Will CFS subjects exhibit altered force production in their matching limb during a 
contralateral limb matching task employing a fatiguing exercise, when compared to 
control subjects? 
3 Will CFS subjects demonstrate altered reference rmsEMG activity during a 
fatiguing exercise, when compared to control subjects? 
4 Will CFS subjects report higher levels of perceived exertion during a fatiguing 
e~ercise, when compared to control subjects? 
1.5 Hypotheses 
It is hypothesised that while performing a fatiguing exercise, the following outcomes will 
occur: 
I CFS subjects will show a greater decline in maximal force over time, when 
compared to control subjects. 
2 CFS subjects will exhibit increased force production of the matching limb in a 
contralateral limb matching task over time, when compared to control subjects. 
3 CFS subjects will demonstrate greater reference nnsEMG amplitude over time, 
when compared to control subjects. 
4 CFS subjects will report higher levels of perceived exertion over time, as measured 
on the CR-10 scale, when compared to control subjects. 
4 
CHAPTER TWO 
LITERATURE REVIEW 
2.1 Introduction 
The significance of effort perception is not only of interest to the athlete, sports scientist 
and clinician, but also to patients diagnosed with effort or fatigue syndromes such as CFS. 
This review will consider the history related to sense of effort research, as well as related 
studies pertaining to perceived exertion. The evolution of a global approach to sense of 
effort will be described along with popular methods related to its quantification. Finally, 
the relationship between sense of effort and the fatigue reported by people with CFS will be 
addressed. 
2.2 Sense of Effort 
Sense of effort is defined by Noble and Robertson (1996, p. 4) as "consisting of the act of 
determining and interpreting sensations arising from the body during activity." The search 
to understand the mediators that give rise to a sense of effort, or what has traditionally been 
called kinesthetic sensibility, has interested researchers for more than a century. Diversity 
in opinion resulted in the emergence of two perspectives regarding the dominant cues for 
effort sense, with contention still existing today. 
The first perspective emerged early in the nineteenth century when Bell (1826, cited in 
McCloskey, 1981 ), postulated that kinesthetic sensibility was based on the conscious 
awareness of infOrmation received through proprioception. Proprioception, which 
5 
describes perceptions of position, force and movement (Jones, 1994 ), is determined by 
aiTerent information signalled to the central nervous system (CNS) Jfom peripheral 
indicators located in the skin. joints and muscles (Voight, liard in, Blackburn, Tippett, & 
Canner, 1996). According to Cafarelli ( 1992). peripheral indicators arc represented by 
Golgi tendon organs. musclt: spindles, skin receptors, muscle receptors embedded in joint 
capsules, and small unmylinated polymodal 'c' fibres. Cafarelli (1992) further notes that 
information p~rtaining to muscle length and tension arc signalled by spindle afTerents and 
Golgi tendon organs, thereby providing proprioceptive information related to position, 
velocity, and force, while muscle and skin receptors provide information assodated with 
pressure, temperature, and the intramuscular concentration of certain ions. 
In contrast to Bell's v1ew, Helmhohz (1866, cited in Cafarelli, 1988) suggested that 
sensations giving rise to a 'force of will' were centrally generated, and arose from 
inneiVation of the efferent pathway without the benefit of feedback from peripheral 
receptors. Bell's original theory however, continued to be supported in the early 1900's by 
Sherrington, who again emphasised peripheral organs and afferent nerves as the primary 
source for effort sensation (McCloskey, 1981 ). Jones (1986) notes that this view was held 
uncontested for over 50 years until experiments by Sperry demonstrated that internal 
signals arising from motor commands did indeed influence perception. Sperry (1950, cited 
in McCloskey, Gandevia, Potter & Colebatch, 1983), later coined the term corollary 
discharge to describe this phenomenon. According to McCloskey, Ebeling, and Goodwin 
(1974), Sperry's work coupled with that by Van Holst and Mittelstoedt, resulted in a shift 
from the predominant belief that peripheral mediators were the primary cue in determining 
sense of effort, to the recognition of the role of centrally generated efferent commands. 
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The importance of centrally generated cllCrcnt signals in determining sense of cfl(Jrt is 
exemplified in contralateral limb matching tasks, which have been employed to investigate 
the cues for ciTort associated with sustained sub-maximal isometric contractions (Cafitrclli, 
1988; Jones, 1995; McCloskey, 197R). During these tasks, a sustained constant f(m;c 
contraction is matched in subjective magnitude by contraction of the contralateral limb. 
McCloskey ( 1978) notes that a contralateral limb matching task provides an objective 
indicator for perceived heaviness, as changes in effort sensation arc reflected by the match 
of the non-reference limb. Results have consistently demonstrated that as fatigue develops, 
subjects tend to overestimate the force when attempting to match a sustained isometric 
contraction of the reference ann. According to many investigators (Aniss, Gandevia & 
Milne, I 988; Cafarelli, 1992; Gandevia, 1997; McCloskey, 1978), this overestimation in 
judgement of reference force indicates the magnitude of the efferent signal as the dominant 
cue for effort sensation. An increase in the efferent signal is further supported by surface 
EMG recordings. According to Cafarelli and Layton-Wood (1986), average surface EMG 
is representative of the summation of action potentials present in individual motor units. 
Malon (1981) notes that average surface EMG increases steadily with fatigue during sub-
maximal contractions. This increased activity indirectly reflects the magnitude of the 
descending motor command needed to recruit additional motor units in order to compensate 
for the partial failure of those already recruited (Bigland-Ritchie 198 i; Malon, 1981 ). 
Studies that demonstrate changes in perceived force, when actual force remains constant, 
fonn the cornerstone for arguments that the CNS incorporates central mediators in 
judgements of force and heaviness (Gandevia, 1997). Other studies however, have 
indicated a role for peripheral mediators. The involvement of peripheral mediators in effort 
sense has been demonstrated in studies where some subjects were able to accurately 
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estimate the force in their rcfCrcncc arm with their matching arm. Accurate estimation of 
reference force by some subjects, have been demonstrated in studies where the reference 
arm was subject to gallamine-induced paresis (Jones & Hunter, I 'JX3h) or vihration of the 
agonist muscle (McCloskey ct al. 1974 ). According to Jones ( 19X3 ), accurate estimation of' 
force in the reference arm indicates attention to afferent feedback, in particular signals 
arising from Golgi tendon organs. McCloskey ct al. (1974) note that attention to feedback 
from afferent sources provides a sense of force or tension, while attention to centrally 
generated efferent commands (corollary discharges) gives rise to a sense of effort. 
Further studies by Cafarelli (1988), Jones (1995), and Lawrie et al. (1997), emphasised a 
complementary rather than an exclusive role for peripheral and central mediators in 
producing effort sensation. This interactive role is described by Cafarelli (1988), who 
suggests that purposeful activity, which is largely initiated from the motor cortex, descends 
through the spinal cord impinr,ing on the motor neuron pool. According to Cafarelli (1988, 
p. 140) "a copy of the central signal probably irradiates to the cardiovascular and 
respiratory centres in order to invoke anticipatory activation of those systems." Indirect 
evidence suggests that a copy of the motor outflow (corollary discharge) is fed forward to 
the sensory cortex, presetting it for anticipated consequences of the motor output (Jones, 
1995). According to Jones (1995), afferent inflow from peripheral receptors is compared to 
the copy of the motor outflow and under normal conditions sensory signals arising from 
peripheral and central indicators are highly correlated. When this relationship is altered, as 
can occur during fatigue, partial curarisation, hemipareRis and cerebellar lesions without 
sensory loss, the motor signal is forced to recalibrate (Cafarelli, 1988; Jones, 1995). This 
recalibration creates a change in the amplitude of the corollary discharge, which reflects the 
8 
magnitude of the voluntary motor commands generated, as well as the efJi.Jrt sensed 
(Lawrie ct al. 1997). 
2.3 Perceived Exertion 
While sense of cOOrt was explored by vanous researchers from a neurophysiological 
perspective, studies by Ekblom and Goldbarg ( 1971) involved a more specific analysis of 
the mediators that determine "perceived exertion'. Perceived exertion differs from the 
traditional concept of sense of effort in that it represents a psychophysiological view of 
indicators that "act individually or collectively to alter tension producing properties of 
skeletal muscle" (Noble & Robertson, 1996, p. I 05). Literature pertaining to perceived 
exertion categorises these indicators as having either a local (peripheral) or central basis. 
Local indicators that give rise to perceived exertion are based on those factors that mediate 
feelings of strain in the exercising muscle (Borg, 1982; Ekblom & Goldbarg, 1971 ), and 
include "muscle lactate, Golgi tendon organ activity and general muscle sensation" 
(Mihevic, 1981, p. 155). Central indicators of perceived exertion are represented by 
pulmonary ventilation and circulation mediators, which include heart rate, ventilatory 
minute volume, respiration rate and oxygen consumption (Mihevic, 1981). 
Just as research in the neurophysiological field has focused on identifYing the dominant 
signal in effort sensation, investigators involved in psychophysiological studies of 
perceived exertion have pursued the same objective. Early studies by Ekblom and 
Goldbarg (1971) involving dynamic exercise, proposed that local factors were dominant in 
work that incorporated the use of small muscles, while work involving large muscle groups 
stressed central mediators of the cardiopulmonary and respiratory system. Later studies 
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incorporating dynamic exercise, demonstrated the importance of exercise tlt1ration. 
Robertson { 1982) noted that during short term work, perception of exertion originating in 
the skin. muscles and joints (local cues) gave rise to sensations of f{m;c and rate of 
contraction, while sensations from the organs of circulation and respiration (central cues) 
became important during prolonged work. Robertson (1982, p. 390} concluded that local 
factors were assumed to provide the primary sensory signals, while "central factors act as 
an amplifier or gain modifier that potentiate the local signals in proportion to the aerobic 
demand". 
2.4 Global Perspective of Sense ofE!Tort 
According to Noble and Robertson (1996), a contemporary model for sense of effort is 
represented by the integration of psychophysiological and neurophysiological mediators. 
These authors continue to suggest that changes in peripheral and respiratory (central) 
muscle tension "are monitored through a final common neurophysiological pathway that 
transmits exertional signals from the motor to the sensory cortex" (p. 1 05). The integration 
of these signals, with psychological and performance mediators, is consciously interpreted 
by the sensory cortex, resulting in a global sense of effort (Noble & Robertson, 1996). 
While multiple signals contribute to a global sense of effort, the dominant signal will 
depend on exercise duration, levels of force, and whether exercise is dynamic or static 
(Cafarelli, 1982; Robertson, 1982). 
2.5 Quantifying Sense of Effort 
Contemporary methods for quantifying sense of effort evolved from early research 
concerned with measuring perceived exertion. In the early 1960's, Borg produced a 21 
point ranked order category scale designed to quantifY perceived exertion (Mihevic, 1981 ). 
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In order to address inherent problems, this scale was later modified resulting in a IS point 
scale known as the 'Borg' or 'RPE' (n1te ofpercdved I!Xcrtion) scale, which was based on 
heart rate values achieved during graded exercise on a cycle ergometer (Borg, 1982). In 
response to criticism that this modilicd scale did not posses ratio properties, Borg 
developed the CR-10 scale (Cafarelli, 1988). The CR-10 scale consists of numbers ranging 
from 0 to I 0 which correspond to various verbal descriptions that rate the perceived effort 
from 'nothing at all" to "very, very hard" (Suminski ct al. 1997). When using this scale, 
subjects are pennitted to go beyond the number I 0, as well as include decimal points (Borg, 
\982). 
While the scales devised by Borg were designed to measure perceived exertion as defined 
by psychophysiological mediators, the very nature of the scales, which require subjects to 
rate how they feel during an exercise, encompass all factors that contribute to a global sense 
of effort. These factors include neurophysiological and psychological mediators, as well as 
performance milieu if ratings are taken during competition (Hassmen, 1996). The all-
inclusive nature of these scales make them valuable tools in quantifying global sense of 
effort. 
2.6 Definition and Aetiology ofCFS 
Stokes, Edwards, and Cooper (1989) note that the significance of effort perception is 
particularly pertinent to patients with effort or fatigue syndromes. CFS represents a 
multifaceted disorder that is characterised by the new onset of profound physical and 
mental fatigue "that lasts for more than 6 months and is serious enough to reduce activity 
by more than 50%" (Sisto et al. \996). Diagnosis is based on the fulfilment of two major 
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criteria, as well as 8 of l1 minor criteria (detailed in Appendix A) (Manu, Lane & 
Matthews, 1992; Jain & DeLisa, 1998), 
The <~etiology of CFS is characterised by speculation and controversy. Common 
suggestions fOr causative agents include psychoJ,')gical fllctors (llickie, !.loyd & Wakefield, 
1995; Woods & Goldberg, 1991), viral infection (Lewis, Cooper & Bennett, 1994), 
immunological abnormalities (Cunningham, Bowles & Archard, 1991; Lloyd, 1990), 
pathophysiological changes in skeletal muscle (Edwards, Newham & Peters, 1991 ), 
metabolic dysfunction (Kennedy, 1991), neuromuscular dysfunction (Jamal & Miller, 
1991), as well a·; neuroendocrine abnonnalities with particular emphasis on hypothalamic-
pituitary-adrenal axis dysfunction (Beam & Wessely, 1994; Behan & Bakheit, 1991). 
Difficulty in assigning a particular aetiology to CFS is attributed to evidence that suggests 
that many symptoms experienced by CFS subjects are not consistent, can occur in nonn.:1l 
subjects, and may reflect secondary changes as a result of reduced activity and consequent 
deconditioning (Edwards, Clague, Gibson & Helliwell, 1994). 
2. 7 Fatigue in CFS 
CFS subjects regularly report the presence of profound physical and mental fatigue which 
can be present at rest and exacerbated by exercise (Edwards, 1984; Gibson, Carroll, Clauge 
& Edwards, 1993). Defming fatigue represents a challenging task, as the definition will 
differ depending on the perspective adopted (Barofsky & Legro, 1991; Petajan, 1996). An 
objective and commonly used approach is offered by a neurophysiological perspective, 
which defines fatigue as a decrease in force generating capacity (Lewis & Haller, 1991). 
This definition also assists in narrowing the origin of the complaint as it recognises that 
fatigue can occur due to impairment at any site in the chain of command for muscle 
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activation. from the higher cortical centres to the interaction of actin and myosin. This 
allows tittiguc to he further classilicd us having either a peripheral or central has is ( l~dwards 
ct al. )t)94). Stokes, Cooper and Edwards ( 1988, p. 278) dclim: c~.:ntral IUtiguc hy 
"impaired motivntion or l:tilurc of' motoneurone drive." Central IUtigu~.: m11y 11risc as a 
result of pathological processes, fear of pain, decreased motivation, impaired concentration 
(Kent-Braun. Sharma, Weiner, Massie & Miller, 1993), low blood sugar (Jones & Round, 
1995), apprehension (Gibson ct al. 1993), as well as intolerance of the discomfort 
associated with fatiguing exercise (Lewis & Haller, 1991 ). Peripheral fatigue is associated 
with various processes concerned with the propagation of muscle action potential or 
generation of force within the muscle fibre (Jones & Round, 1995). These processes which 
include metabolic depletion, accumulation of metabolites or damage (Jones & Round, 
1995), may result in impainnent to neuromuscular transmission, sarcolemma excitation or 
excitation-contraction coupling (Edwards et al. 1991; Wcssely & Edwards, 1993). 
Many studies which have investigated muscular fatigue in CPS suggest a strong central 
component (Beam & Wessely, 1994; Kent-Braun et al. 1993; McCully, Sisto & Natelson, 
1996). Support for a central basis for fatigue in CFS is provided by studies that 
demonstrate nonnal peripheral neuromuscular function (Kent-Braun et al. 1993; Jamel & 
Miller, 1991; Lloyd, Hales & Gandevia, 1988), as well studies that demonstrate an inability 
by some CFS subjects to fully activate skeletal muscle during intense sustained exercise 
(Kent-Braun et al. 1993; Stokes et al. 1989). Evidence for histochemical abnonnalities in 
the skeletal muscles of some CFS patients are generally not considered significant and 
often reflect dcconditioning (Edwards et al. 1994; McComas, Miller & Gandevia, 1996). 
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2.8 Sense Qf Ellllrt in CFS 
Subjects with CFS nlkn describe an increased sense of cmlrt associated with exercise when 
compan:d t<l hcaltl1y subjects (Edwards. 1992; Lloyd & Pender, 1994; Miller, Allen, 
Gandcvia. 1996; Wcsscly & Edwards, 1993 ). Abnormal cll(Jrt sensation in CFS suhj~.:cts 
has been demonstrated o1ftcr peak treadmill exercise {Riley, O'Brien, McCluskey, Bell & 
Nicholls. 1990), absolute workloads of incremental treadmill exercises (Sisto ct al. 1996), 
and during sub-maximal and maximal isometric contractions (Brouwer & ~acker, 1994; 
Kent-Braun et al. 1993). Gibson et al. (1993) further demonstrated an abnormal sense of 
effort in CFS subjects during an incremental cycle ergometer test. In contrast to these 
studies, Lloyd eta!. (1991, p. 96) demonstrated no difference in effort sensation for 
repetitive sub-maximal contractions between CFS and control subjects. 
2.9 Conclusion 
While many studies have demonstrated that CFS subjects rate the effort associated with a 
comparable exercise higher than healthy subjects, "suggesting an increased 'gain' in the 
perception of physiological signals" (Edwards et al. 1991, p. 834), results have been 
equivocal. To date there have been no studies that have utilised a contralateral limb 
matching task in order to investigate fatigue and effort perception responses in CFS 
subjects. Employment of such a tool will provide a more objective indicator of sense of 
effort in CFS subjects, and may indicate an association between mediators for sense of 
effort and the symptom of fatigue reported by CFS patients. If such an association can be 
established, then this may imply a central basis for the fatigue experier.ce in Ct•S. Refining 
the nature of fatigue experienced in CFS will assist in defining the aetiology of the disorder, 
a.c;; well as determining the effectiveness of any therapeutic intervention. 
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CHAPTER HIREE 
METIIOil 
3.1 Subject Details 
This study consisted of a control and a CFS group, with six subjects in each group who met 
selected criteria (detailed in sections 3.1.1 and 3.1.2). Subject details are contained in Table 
3.1. Subjects were infonned of all procedures and completed the following forms prior to 
testing: 
Consent tOnn: 
Activity Questiormaire: 
Medical Questionnaire: 
Profile of Mood States 
(POMS) Questionnaire: 
Described the purpose of the study, the associated protocol as 
well as possible side effects from the exercise (Appendix B). 
Based on a model by Sharkey (1991), and designed to determine 
subject's activity level (Appendix C). 
Designed to screen for medical or neuromuscular conditions that 
could exclude potential subjects from the study (Appendix D). 
A 65 five-point adjective rating scale designed to assess each 
subject's mood state at the time of testing (Appendix E). 
Subjects were informed that they were freo to withdraw from the study at any time without 
prejudice. Ethical approval had been granted for this study by the Edith Cowan University 
Ethics Committee prior to testing. 
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3.1.1 CFS Subjects 
Subjects were recruited from QEII Medical Centre, general practitioners and from the CFS 
Support Association. Subjects consisted of 4 males and 2 females, medically diagnosed as 
suffering from CFS triggered by an infectious episode, and contracted in the !dst 6 months 
to 3 years. Relevant clinical details are contained in Table 3.1. Values (mean ± SO) for 
age, weigbt, and height were 36.6 ± 16.2 years, 84.0 ± 21.1 kg, and 179.1 ± 12.2 em 
respectively. Activity levels ranged from sedentary to highly active, while all subjects were 
rigbt hand dominant. 
3.1.2 Control Subjects 
The control group consisted of 4 males and 2 females recruited from friends and colleagues 
of the investigator, as well as from the university population. Subjects were selected on the 
basis of being matched to CFS subjects according to their activity level (as determined by 
an activity questionnaire), as well as by their gender, age, weight, and height. Values 
(mean± SD) for age, weight, and heigbt were 37.3 ± 15.8 years, 83.0 ± 15.7 kg, and 176.5 
± 8.5 em respectively. While one subject was noted to be ambidextrous, all reported as 
rigbt hand preferred. 
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Table 3.1 
Subject Particulars 
Subjects Gender Age Weight Height Activity Presenting infection and 
(yrs) (kg) (em) level time since diagnosed 
with CFS 
Control No I Female 39 60 167 Moderate 
CFS No I Female 37 61 164 Moderate URTJ* 
24 months 
Control No 2 Female 25 85 170 Moderate 
CFS No2 Female 24 80 169 Moderate Gastroenteritis 
9 months 
Control No 3 Male 25 75 178 Highly 
Active 
CFS No3 Male 23 68 178 Highly URTJ 
Active 10 months 
Control No 4 Male 61 86 172 Moderate 
CFS No4 Male 58 80 178 Moderate URTI 
32 months 
Control No 5 Male 51 108 182 Sedentary 
CFS NoS Male 55 120 189 Sedentary Glandular Fever 
15 months 
Control No 6 Male 23 84 190 Highly 
Active 
CFS No6 Male 23 95 197 Highly Glandular Fever 
Active 18 months 
• Upper Respir•tory Tract Infection 
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3.2 Equipment 
Equipment used during the pilot study and formal testing session are listed below and 
featured in Figures 3.1 and 3.2. 
Figure 3.1 
1 Tensiometer strain gauge 
2 IBM Processor 
3 Force chair with 
restraining straps 
4 Chestpad 
5 Padded board & C-
clamps 
6 Wrist protectors 
7 5 Volt power supply & 
batteries 
Surface EMG electrodes 
Ag/ AgCI, Medi trace 
( approx 1 sq cm in size) 
CR-10 Scale 
Tape recorder and tape 
Excel and SPSS software 
Cotton wool 
Alcohol swabs 
Photograph of equipment used during the pilot study and formal testing. 
Photograph illustrates side on view of a subject restrained in the force chair in preparation 
of testing. 
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Figure 3.2. Front view of a subject restrained in the force chair prior to protocol. 
3 .2.1 Calibration Procedure 
l 
' Prior to the arrival of each subject, both strain gauges were calibrated using fixed weight 
calibration plates. This procedure entailed placing a hook on the wrist strap of each 
individual strain gauge and cumulatively hanging a total of four fixed weight plates from 
the hook. Checks were made to ensure that the resulting force matched a preset line 
visually displayed in the AMLAB software, that was representative of the Newtons 
expected for each weight. Each fixed weight plate weighed 11.34 kg, which equated to 
111 .245 Newtons. To confirm linearity in strain gauge output, a regression line was 
established between Volts and Newtons and is displayed in Appendix F. 
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3.3 Recording and Analysis of Electromyography 
Surface EMO electrodes were used to measure electrical activity in the biceps brachii of 
both arms. Before electrodes were attached, the relevant skin area was shaved, cleaned 
with alcohol, then dried. To assist in locating the muscle belly, subjects were asked to hold 
their arm in 90° of elbow flexion and perform a contraction in the arm. A pair of electrodes 
were then placed on the mid point of the muscle belly, no more than 25 mm apart, while the 
earth electrode was attached to the medial epicondyle of the left humerus. Once surface 
electrodes were in place, electrode leads were attached and connected to the preamplifier on 
the IBM computer. Subjects were then asked to perform a small contraction of both arms 
in order to test EMO output. An example of electrode placement is shown in Figure 3.2. 
EMO data were recorded in Volts and stored during testing using AMLAB data diagnostic 
software operating an IBM computer. EMO data were amplified by 218, sampled at 1000 
Hz, and averaged (root mean squared - rms). Analysis of rmsEMO data involved the 
offline selection and averaging of half a second of rmsEMO data that were applicable to 
relevant contractions. Selection of data was achieved through the placement of cursors 
(available in AMLAB software); on either side ofrelevant data. 
Figure 3.2. Photograph demonstrating the placement of electrodes on subject's arm. 
20 
3.4 Determination of Maximal Voluntary Contraction (MVC) and Recording of Force_ 
Datv 
In order to limit input from synergist muscles when determining MVC, subjects were 
resrrained in a force chair with a velcro strap 13stcned around the waist, and a clamped 
padded board and pillow placed against their chest (refer to Figure 3.1). The padded board, 
used also for placing the anns on, was adjusted for each subject's height. Wrists were 
padded and strain gauge straps placed around them. Both arms were positioned on the 
padded board in 90° of elbow flexion, with wrists in the supine position. In order to 
achit:ve an MVC, subjects were informed that when given the cue, they were to pull the 
wrist of their reference ann as hard as possible toward their corresponding shoulder for 
approximately 3 - 4 seconds. When the cue was given, the investigator verbally 
encouraged the subject in performing the task. Three MVC's were performed with a two-
minute rest interval between each contraction. Force data were recorded and stored using 
AMLAB diagnostic software operating an IBM computer. Force data relating to MVC and 
other relevant contractions, were selected offline and averaged through the employment of 
cursors contained in AMLAB software. 
3.5 CR-10 Scale 
Prior to testing, subjects were acquainted with the use of the CR-1 0 scale, and carefully 
instructed that RPE values reported during testing should reflect the effort sensed as a 
consequence of the ·task. RPE data was recorded in specific data collection sheets 
(Appendix G), while an illustration ofthe CR-10 scale can be found in Appendix H. 
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3.6 Pilot Study 
Prior to formal testing a pilot study was employed in order to test the reliability of 
measurements, as well as to Huniliarisc the investigator with equipment. Five subjt.'(,;ts 
(who were not part of the main study) participated, with each subjl.'Cl tested on two separate 
occasions. The protocol, which was identical tbr both occasions and applied separately to 
both arms, consisted of each subject performing three MVC's followed by single 
contractions in the same arm that represented 80%, 60%, 40% and 20% of their highest 
MVC. To assist subjects in achieving target sub-maximal contractions, target force and 
actual reference arm force were displayed on a PC monitor. Contractions were performed 
in random order with a two-minute rest interval between each contraction. 
3. 7 Study Design 
The testing procedure took approximately 65 minutes and consisted of the attainment of 
baseline measurements (10 minutes), the fatiguing task (45 minutes) and a recovery 
protocol (lO minutes). Prior to testing, completed questionnaires were reviewed, the 
procedure was demonstrated, and any questions or concerns addressed. 
3. 7.1 Baseline Measurements 
In order to establish baseline values, all subjects commenced the session by performing 
three MVC's in their reference (non-dominant) arm. The greatest MVC for the reference 
ann was measured, and subjects were then asked to perfonn contractions in this ann 
equating to 70%, 50% and 30% of their largest MVC. Target force was displayed on a PC 
monitor along with reference arm force. Contractions were made in random order and 
lasted for approximately eight seconds. Approximately four seconds after the 
commencement of each sub-maximal contraction, subjects attempted to match the force of 
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the reference arm with the dominant arm. Both contractions were then h~ld tOr a fUrther 
fOur seconds with no visual cue being given tOr attempted matches made by the dominani 
arm. Associated RPE scores were recorded fol' each contraction made in the reference arm. 
The entire procedure was then repeated with MVC's and sub~maximal contractions 
performed in the dominant arm, along with attempted matches made this time by the 
reference arm. RPE values were not recorded for the contractions made during this part of 
the procedure. Force and nnsEMG values were recorded for all contractions. 
3.7.2 Fatiguing Task 
The fatiguing task consisted of intermittent sub-maximal contractions (7 s duration, 3 s rest 
intervals) of the reference (non-dominant) arm, at a force equivalent to 30% ofMVC of the 
reference ann, for 45 minutes. Visual feedback to subjects consisted of the target force and 
reference ann force displayed on a PC monitor. The reference force output was monitored 
by the investigator throughout the procedure to ensure subject compliance. Each minute, 
subjects were instructed to match the force of the reference ann with their dominant arm 
(without the benefit of visual feedback for the dominant arm), except for every fifth minute 
when an MVC was performed in the reference arm. Recordings of force and rmsEMG 
activity were made every minute for 30 seconds, while RPE was recorded 30 seconds after 
each matching or MVC contraction. 
3. 7.3 Recovery ProtocQl 
At the completion of the fatiguing task, subjects commenced a recovery protocol that 
involved them performing a 30% of MVC of the reference arm. Target force was visually 
displayed on a PC monitor along with reference ann force. After three seconds, subjects 
were asked to match the force of the reference arm by contraction of the dominant arm, 
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without the benefit of visual feedback lOr the matching arm. Aller the match was 
attempted, subjects were then encouraged to perform a MVC in the rciCrcncc arm. This 
procedure occurred at I, 3, 5 and 10 minutes allcr completion of the f3tiguing task. 
3.8 Data and Statistical Analysis 
This study involved four protocols, with data and statistical analysis varying for each one. 
Values in the results section are presented as mean ± standard deviation unless otherwise 
stated. All relevant raw data pertaining to results can be found in Appendices I (pilot 
study) and J (fonnal testing). In order to avoid repetition, it is intended that this entire 
section be read in conjunction with chapter four. 
3.8.1 Data Analysis of Pilot Study Results 
Results of the pilot study were analysed using a Pearson product-moment correlation 
coefficient for MVC force and nnsEMG data in the right and left anns of all subjects. 
Method error (calculation demonstrated by Thorstensson, cited in MacDougall, Wenger & 
Green, 1991) and coefficients variation were calculated for force and nnsEMG data for 
MVC, as well as contractions made at 20, 40, 60, and 80% of MVC. 
3.8.2 Data and Statistical Analysis of Baseline Measurements 
Responses to the POMS questionnaire were scaled, averaged, and presented as standard T 
scores. According to McNair, Lorr and Droppleman (1992, p. 2) "the mean standard score 
for each scale is 50 with a standard deviation of 10". MVC results were recorded in 
Newtons for force and Volts for nnsEMG, while all submaximal force and rmsEMG data 
were expressed as percentages of individual peak MVC values. RPE data were recorded 
according to numeric values pertaining to the CR-1 0 scale. Independent t tests were 
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applied to individual data so to test fOr statistically significant differences between groups 
Means were also calculated for MVC f{>rcc, MVC rmsEMO, matching force, matching 
nnsEMG, ;~nd RPE data, and compared between groups in order to identifY trends. 
3.8.3 D~'ta and Statistical Analysis of Results Recorded During the Fatiguing Task 
MVC values were recorded prior to and !Or every fifth minute during the fatiguing task. 
An ANOVA with repeated measures was performed on individual nonnalised MVC force 
and MVC nnsEMG values in order to test fOr any statistically significant difference 
between groups and between group by time. Means for each time interval were calculated 
and compared between groups in order to identity trends. 
Apart from every fifth minute, matching force, matching rmsEMG and reference nnsEMG 
were recorded for every other minute during the 45 minute task. All individual data were 
expressed as a percentage of individual peak MVC values detennined prior to the fatiguing 
task. Individual normalised data were then averaged for each four-minute interval 
preceding MVC production. An ANOV A with repeated measures was performed on this 
data in order to detennine if any statistically significant difference occurred between groups 
and between group by time. In order to identify trends, means tbr each four-minute time 
intervals were calculated and compared between groups. A Pearson product-moment 
correlation coefficient was perfonned on means for matching force and reference nnsEMG 
in both CFS and control groups, in order to determine if an association existed between 
these two variables. 
RPE data were averaged for the first and every fifth minute. An ANOV A with repeated 
measures was applied to this data to test for any statistically significant ditlbrence between 
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groups and between group by time. In order to identitY trends, means fhr each time 
intervals were calculated and compared bCtWCcn groups. 
3.8.4 Data and Statistical Analysis of Results Recorded During Recovery 
MVC force, MVC nnsEMG, matching force, matching rmsEMG and reference rmsEMG 
were recorded at one, three, five and ten minutes post the fatiguing task. Independent t tests 
were performed on individual normalised values for each time interval in order to 
determine if any statistically significant difference occurred between groups. Means tbr 
each time interval were calculated and compared between groups in order to identify any 
trends. 
3.9 Delimitations and Limitations 
3.9.1 Subject Delimitations 
Subject delimitations imposed by the investigator, related to attempts to match CPS 
subjects with control subjects, as well as selecting only Cl 'S subjects who had been 
medically diagnosed with CPS as triggered by an infectious incident. Diagnosis also 
needed to be made within a 6 month to 3 year period. Candidates who were involved in 
any upper body strength training were also excluded from this study. 
3.9.2 Subject Limitations 
While every attempt was made to appropriately match the CFS group with the control 
group, limitations related to honest responses to the questionnaires, strength, endurance 
capabilities, motivational levels, tolerance of pain, fibre type and other psychological 
factors that would impact on subjective ratings of perceived exertion. 
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3.9.3 Research Limitations 
This study was limited by time, with consequent constraints in the number of subjects who 
could be tested. Twitch interpolation, which allows for the objective assessment of MVC, 
was also not employed due to time constraints. 
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CHAPTER FOUR 
RESliLTS 
4.1 Pilot Study Results 
A Pearson product-moment correlation coefficient for MVC force in the right and left arms 
resulted in r = 0.98 (Rsq = 95%) and r = 0.97 (Rsq = 94%) respectively (Figure 4.1 ). 
Results for rmsEMG values equated tor= 0.94 (Rsq = 88%) in the right ann and r = 0.89 
(Rsq = 80%) in the left arm (Figure 4.2). These values indicated a strong association 
between tests, suggesting that the testing procedures and equipment used in this pilot study 
produced reliable results in relation to MVC values. Method error for MVC in the right 
arm was 9.3 N for force and 0.018 V for nnBEMG, equating to coefficient variations of3% 
and 8% respectively. MVC in the left ann .resulted in a method error of 24.6 N for force 
and 0.028 V for nnsEMG and is represented by coefficient variations of?% and II%. 
The relationship between force and rmsEMG in the right and left arms for both tests is 
presented in Figure 4.3. Method error and coefficient variations for contractions 80, 60, 40 
and 20% of MVC were calculated and resulted in coefficient variations ranging from 3 -
10% for force, with rmsEMG values ranging from 15 - 25%. The larger method error 
associated with rmsEMG results most likely pertains to the highly specific and sensitive 
nature associated with the importance of electrode placement in detennining the motor unit 
populations sampled on each occasion (De Ia Barrera & Milner, 1994). 
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Figure 4.1 Test-retest correlation for maximum voluntary elbow flexion in the left and 
right arms (n = 5). Each result represents the peak force value obtained from three maximum 
efforts on separate occasions. 
Left Arm Test-Retest Correlation (rmsEMG) Right Arm Test-Retest Correlat ion (rmsEMG) 
.4 ,------------------,--, 
.40r-------- ----------, 
0 
.3 
.30 
0 
I 
' 
I r = 0.89 I .20 I r = 0.94 I 2 0 
C. 0 
0 
~ 
0 en ~ .1 ,..._ ___ ~-----~--------.1 Q) I- .10 
.1 .2 .3 .4 .1 .2 .3 
Test 2 (Volts) Test 2 (Volts) 
Figure 4.2. Test-retest correlation for maximum voluntary elbow flexion rmsEMG activity 
in the left and right arms (n = 5). Each result represents the average of 0.5 seconds of selected 
data sampled at 1 OOOHz. 
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Test-retest results for pilot study (n = 5). Graph A represents normalised rmsEMG to 
normalised force for contractions representative of 20, 40, 60, 80% of MVC and MVC in the left arm. 
Graph B represents normalised rmsEMG to normalised force for contractions representative of 20, 40, 
60, 80% ofMVC and MVC in the right arm. Results are mean± SEM for five subjects. 
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4.2 Results for Baseline Measurements Made Prior to Fatiguing Task 
4.2.1 POMS Results for CFS and Control Subjects 
Prior to testing, subjects completed a POMS questionnaire designed to assess their mood 
state. Analysis of mean T scores (illustrated in Table 4.1) indicated that there were no 
significant differences between groups for depression, anger, or confusion. CFS subjects 
however, reported a significantly higher level of tension (P < 0.05) and fatigue (P < 0.0 I), 
which was associated with a significantly lower degree of vigour (P < 0.01), as compared 
to controls. 
Table 4.1 
CFS and Control Subjects' T Scores (mean ± SD) for Specific Psychological Variables 
Measured In POMS Questionnaire 
CFS Controls 
Psychological Variables (n =6) (n=6) 
Tension 46.7 ±·9.7* 36.2 ± 4.3 
Depression 43.8 ± 8.3 40.5 ± 3.0 
Anger 47.2 ± 5.8 42±3.9 
Vigour 39.3 ± 9.3** 63.2 ± 7.4 
Fatigue 64.5 ± 5.2** 38.5 ±4.8 
Confusion 50.5 ± 16.8 37.8 ±4.0 
' and** denote significant differences between groups *(P < 0.05), while '' (P < 0.01). 
Independent t tests were two-tailed and included a 95% confidence interval. 
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4.2.2 MVC Force Results for CFS and Control Groups 
While elbow flexor MVC strength was similar between groups, CFS subjects proved to be 
slightly stronger (Figure 4.4). This is demonstrated by mean values of303.5 ± 121.7 N for 
the CFS group as compared to 288.0 ± 61.7 N for controls in the reference arm, with a 
slightly smaller difference in the matching arm (320.6 ± 127.7 N vs 313.5 ± 67.3 N). There 
were no significant differences between the reference and matching arms in either group. 
Baseline MVC Force 
400 --.--~~~~~~~~~~~~~~ 
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Reference Arm Matching Arm 
• CFS 
D Control 
Figure 4.4. MVC force values (mean+ SEM) for reference and matching arms in CFS 
(n = 6) and control (n = 6) groups. 
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4.2.3 MVC rmsEMG Results for CFS and Control Groups 
While there was no significant differences between groups for MVC rmsEMG, comparison 
of mean values (illustrated in Figure 4.5) indicated higher amplitude in the reference ann 
for the control group (0.23 ± 0.09 V), as compared to the CFS group (0.18 ± 0.10 V). 
Results for the matching arm were also higher for the control group (0.23 ± 0.09 vs 0.18 ± 
0.11 V). 
Baseline MVC rmsEMG 
0.3 --.-------------------, 
0.25 -t-----1- --------11-----l 
0.2 -+---~-,~-
0.15 -+---
0.1 
0.05 -+---
0 --
Reference Arm Matching Arm 
• CFS 
DControl 
Figure 4.5. MVC rmsEMG values (mean + SEM) for reference and matching arms in CFS 
(n = 6) and control (n = 6) groups. 
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4.2.4 Matching Force Values for Sub-Maximal Contractions 
Figure 4.6 illustrates the forces achieved when subjects attempted to match varying sub-
maximal contractions of 30, 50 and 70% ofMVC held in the reference arm. Comparison of 
means demonstrated that both groups underestimated the reference force, with the greatest 
difference occurring with attempts to match a 70% of MVC. The difficulty in matching a 
high level reference force is consistent with the findings of Jones and Hunter (1983a), who 
reported that as the magnitude of a reference force increased, the ability to match it 
decreased. Results, while not statistically significant, demonstrated that CFS subjects 
produced greater averaged matches when compared to controls. Attempts to match a 70% 
MVC held in the reference arm resulted in a match of 51.1 ± 16.9% for the CFS groups, as 
compared to 45.0 ± 8.7% for controls. Reference forces of 50 and 30% ofMVC resulted in 
matches of 41.3 ± 10.1% and 28.3 ± 9.3% for the CFS group and 36 ± 8.7% and 22.1 ± 
4.1 % for controls. 
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Figure 4.6. Normalised matching force (mean + SEM) for CFS (n = 6) and control (n = 6) 
groups for 70, 50, and 30% MVC held in the reference arm. 
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4.2.5 Matching rmsEMG Values for Sub Maximal Contractions 
Matching rmsEMG for both groups followed a similar pattern to matching force (refer 
4.2.4), in that matching rmsEMG means were below the reference target for each sub-
maximal contraction (Figure 4.7). Results between groups were variable as demonstrated 
by the control group displaying higher matching rmsEMG when attempting to match a 70% 
MVC held in the reference arm, while the CFS group produced greater rmsEMG amplitude 
when attempting to match a 50% and 30% MVC reference force. There were no significant 
differences between groups in matching rmsEMG for sub-maximal contractions. 
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Figure 4.7. Normalised matching nnsEMG (mean + SEM) for CFS (n = 6) and control 
(n = 6) groups for 70, 50 and 30% ofMVC held in the reference arm. 
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4.2.6 RPE Responses During Sub-Maximal Contractions 
Comparison of mean RPE values for contractions performed at 70%, 50%, and 30% of 
individual MVC are illustrated in Figure 4.8. Significant differences between groups were 
observed, with the CFS group reporting higher RPE scores associated with all three sub-
maximal contractions. The greatest difference between groups for RPE scores occurred for 
contractions made at 50% MVC (P ~ 0.001). This contraction elicited responses of 
'somewhat strong' to 'very strong' from CFS subjects, while controls rated it as 'weak' to 
' moderate' . Contractions performed at 70% ofMVC elicited the least significant difference 
between groups (P ~ 0.005), with responses of 'very strong' reported by CFS subjects and 
' strong' by controls. Elevated RPE scores reported by CFS subjects reflect the larger force 
production made by these subjects when attempting to match sub-maximal contractions 
(refer to section 4.2.4). 
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Figure 4.8. RPE values (mean + SEM) for 70, 50, and 30% of MVC performed in the 
reference arm for CFS group (n = 6) and control group (n = 6). ** Denotes significant 
difference between CFS and control groups (P < 0.01). 
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4.3. Fatiguing Task 
4.3.1 MVC Force Results During the Fatiguing Task 
Figure 4.9 illustrates a similar pattern in normalised mean MVC force for both groups over 
the 45 minute task. Both groups demonstrated a large decrement in force between the 
initial MVC and the five-minute mark (12% for CFS and 13% for controls), with force 
fluctuating between groups until the 35 minute mark. At this point MVC force was 
identical for both groups (72 ± 9%). The final ten minutes saw MVC force fall slightly 
more in the control group than in the CFS group, with final values for mean MVC force 
represented by 66 ± 18% and 62 ± 8% for the CFS and control groups respectively. An 
ANOV A with repeated measures demonstrated no significant difference in scores between 
groups. 
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Figure 4.9. Normalised MVC force (mean ± SEM) for CFS (n = 6) and control (n = 6) 
groups recorded prior to and for every fifth minute during the fatiguing task. The first data 
point denotes the greatest MVC force achieved during baseline measurements and 
represents 100%. 
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4.3.2 MVC rmsEMG During the Fatiguing Task 
MVC nnsEMG results demonstrated a similar pattern between the two groups for the 45 
minute task (Figure 4.10). While a greater decline in MVC rmsEMG amplitude was 
evident in the CFS group between the initial recording and the five-minute mark (25% as 
opposed to 8%), both groups produced similar amplitude between the 10 and 35 minute 
mark. In the last ten minutes of the task, MVC rmsEMG amplitude rose slightly more in 
the control group than in the CFS group, resulting in a final difference of 8% between 
groups. Differences between groups were not significant. 
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Figure 4.10. Normalised MVC rmsEMG (mean ± SEM) for CFS (n = 5) and control (n = 
6) groups, recorded prior to and for every fifth minute during the fatiguing task. The first 
data point denotes MVC rmsEMG achieved during baseline measurements and represents 
100%. 
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4.3.3 Matching Force During the Fatiguing Task 
While normalised means for matching force were similar between groups (fluctuating 
between 4% and 7%), the CFS group produced a greater matching force for each respective 
time interval during the 45 minute task (Figure 4.11). Trends indicated that while both 
groups underestimated reference force for a large part of the task, matching force began to 
rise slightly for both groups at the 29 minute mark. The control group demonstrated a 
larger increase in matching force production between the 34 and 39 minute mark (3% vs 
1 % ), while a dramatic increase in matching force production was evident for the CFS group 
in the final five minutes of the task (7% vs 4%). Larger matching force production by the 
CFS group was also evident during baseline measurements, as was the tendency by both 
groups to underestimate the reference force. Differences between groups were not 
significant. 
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Figure 4.11. Normalised matching force values (mean ± SEM) for CFS (n = 6) and control 
(n = 6) groups, averaged for the four minute intervals prior to each MVC. 
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4.3.4 Matching rmsEMG During the Fatiguing Task 
Trends for matching nnsEMG were similar between groups, with the CFS group 
demonstrating greater amplitude than controls for each respective time interval during the 
45-minute task (Figure 4.12). This difference however, was reduced to only 5% by the end 
of the task. Trends were also similar to those produced for matching force. Matching 
rmsEMG amplitude began to rise for both groups toward the end of the task, increasing 
slightly earlier for the CFS group, as represented by a 2% increase between the 29 and 34 
minute mark of the task. During the 34 and 39 minute mark, both groups experienced a 
similar increase in amplitude, with a larger increase being demonstrated by the control 
group for the last five minutes of the task (6% as compared to 2% for the CFS group). 
Higher matching rmsEMG amplitude was also demonstrated by the CFS group when 
attempting to match a similar contraction during baseline measurements. Differences 
between groups were not significant. 
Matching rmsEMG During Fatiguing Task 
lt,,,o 50 
0 
o E 40 > ... 
:E <( 
30 Cl) 0, 
C) -~ 
cu .c 20 l ...... 0 l C....., ! l l ! ! Cl) cu l ~ :t 10 -- - -- - - ---
Cl) 
a. 
0 
~CFS 4 9 14 19 24 29 34 39 44 
Control Time (minutes) 
Figure 4.12. Normalised matching rmsEMG (mean± SEM) for CFS (n = 6) and control 
(n = 6) groups, averaged for four minute intervals prior to each MVC. 
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4.3.5 Reference rmsEMG During the Fatiguing Task 
Reference rmsEMG amplitude remained fairly constant between groups for the first 30 
minute of the task. This was then followed by a gradual increase in amplitude, with both 
groups producing identical results at the 34 minute mark (28% respectively). At this point, 
amplitude in the CFS group increased at a faster rate as demonstrated by a 10% increase 
between 34 and 44 minutes, as compared to a 5% increase for controls for the same period. 
Once again, trends for reference rmsEMG were similar to those produced by matching 
force and matching rmsEMG, in that a greater increase in values was demonstrated towards 
the end of the task. Differences between groups were not significant. 
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Figure 4.13. Normalised reference rmsEMG (mean ± SEM) for CFS (n = 5) and control 
(n = 6) groups, averaged for four minute intervals prior to each MVC. 
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4.3.6 Correlation Between Matching force and Reference rmsEMG Results 
During the Fatiguing Task 
The association between matching force in the dominant arm and nnsEMG amplitude in 
the reference arm is demonstrated by Pearson's correlation coefficients. A Pearson's 
correlation coefficient for normalised matching force and normalised reference rmsEMG, 
averaged for nine separate time intervals during the fatiguing task, resulted in r = 0.88 for 
the CFS group and r ~ 0.96 for the control group (Figure 4.14). A strong association 
between matching force and reference nnsEMG is represented by squared correlation 
coefficients of 77% and 92% for the CFS and control groups respectively. These results 
support studies by Jones and Hunter (I983a) that demonstrated that as matching force 
increases, reference nnsEMG also increases in a parallel manner. 
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Figure 4.14. Correlation of normalised reference rmsEMG and normalised matching force, 
averaged over nine separate time intervals during the fatiguing task for the CFS group 
(n = 5) (Graph A), and for the control group (n = 6) (Graph B). (Only eight points shown 
as two represent the same values). Time intervals represent the 4th, 9th, 14th, 19th, 24th, 
29th, 34th, 39th, and the 44th minute marks of the fatiguing task. 
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4.3.7 RPE During the Fatiguing Task 
Higher RPE scores were reported by the CFS group for the entire 45 minute task, with 
differences in scores being signilicantly different between groups (P < 0.05), but not for 
group by time results (refer section 3.8.3). As well as reflecting higher force and nnsEMG 
values produced during the fatiguing task by the CFS group, elevated RPE values further 
reflect the higher RPE responses given by CFS subjects to all sub-maximal contractions 
prior to the fatiguing task. Noticeable differences in mean RPE scores were evident during 
~ fLrst minute of the fatiguing 1-Jsk when CFS subjects described the associated 
.. vntractions as being 'weak' to 'moderate' (2.5 ± 1.2), as opposed to responses of 'very, 
very weak' elicited by controls (0.8 ± 0.2). During the last ten minutes of the protocol, all 
but one CFS subject classified the final contractions as 'maximal' or 'almost maximal', 
while controls on average, rr>ted the same contractions as 'very strong'. White trends in 
Figure 4.15 indicate a unifonn difference between CFS and control subjects for RPE 
responses, it should be noted that the CR -10 scale is not a linear scale. 
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Figure 4.15. RPE data (mean ± SEM) for CFS (n = 6) and control (n = 6) groups for 
contractions performed in the reference arm during the first and every fifth minute of the 
fatiguing task. Significant differences (P < 0.05) were reported between groups but not for 
groups by time. 
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4.4 Recovery 
4.4.1 Matching Force During Recovery for CFS and Control Groups 
Attempts by the CFS and control groups to match a 30% MVC held in the reference arm 
with the non-dominant arm during recovery proved reasonably accurate, with mean results 
for each time interval listed in Table 4.2. Attempts to match an equivalent force during 
baseline measurements produced lower force production as demonstrated by matches of 
28.3% and 22.1% for CFS and control groups respectively. Differences between groups 
were minimal during recovery and are represented by 0.1% at one minute, 0.6% at three 
minutes, 4.5% at five minutes, and 1.6% at the ten minute mark. An independent t test 
performed on individual normalised values for matching force between groups 
demonstrated no significant difference between groups. 
Table 4.2 
Mean Results For Normalised Matching Force for the CFS and Control Groups Recorded at 
I, 3, 5, and 10 Minutes during the Recovery Protocol. 
Recovery Time CFS group Control e:roup 
(n = 6) (n =6) 
I minute 32.1 ± 8.8% 32.3± 11.1% 
3 minutes 33.1 ± 10.7% 33.8± 13% 
5 minutes 35.2± 6.4% 30.6± 11.3% 
10 minutes 31.3 ± 6% 29.6± 10.6% 
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4.4.2 Matching rmsEMG During Recovery for CFS and Control Groups 
Results for averaged normalised matching rmsEMG are presented in Table 4.3. As well as 
indicating higher rmsEMG amplitude in the CFS group for the entire protocol, it was 
notable that the CFS group experienced a greater decline in rmsEMG amplitude over time 
(6.4%) than the control group (1.6%). An independent t test performed on individual 
nonnalised values revealed no significant differences between groups. 
Table 4.3 Mean Results For Normalised Matching rmsEMG for the CFS and Control 
Groups Recorded at 1. 3, 5. and 10 Minutes during Recovery Protocol. 
Recovery Time CFSeroup Control group 
(n = 5) (n = 5) 
I minute 35.6 ± 11.3% 26.4 ± 16% 
3 minutes 30.8 ± 11.3% 22.0 ± 13.2% 
5 minutes 29.2± 12.6% 23.8 ± 18.6% 
10 minutes 29.2±9.7% 24.8 ± 21.5% 
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4.4.3 Reference nnsEMG During Recovery for CFS and Control Grou..J21:! 
Results for averaged normalised reference rmsEMG are presented in Table 4.4. Reference 
nnsEMG was slightly higher in the CFS group when compared to the control group. 
Differences were 6.0% at one minute, 7.2% at three minutes, 5.8% at five minutes, and 
2.9% at ten minutes. There were no significant differences between groups for reference 
rmsEMG amplitude. 
Table 4.4 
Mean Results For Nonnalised Reference nnsEMG for the CFS and Control Groups 
Recorded at I, 3, 5, and 10 Minutes during Recovery Protocol. 
Recovery Time 
1 minute 
3 minutes 
5 minutes 
10 minutes 
CFSgroup 
(n = 5) 
35 ± 21.4% 
35.4 ± 24.4% 
36.0±24.2% 
34.6± 24.9% 
Control grouu 
(n =6) 
29.0 ± 10.4% 
28.1 ± 10.3% 
30.1 ± 13.7% 
31.6 ± 14.4% 
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4.4.4 MVC Force Data for CFS and Control Groups During the Recovery Protocol 
Comparison of normalised MVC force data between groups indicated that the CFS group 
showed a faster recovery of MVC force (Figure 4.16). One minute into recovery, results 
were similar (72.8 ± 7.3% vs 73.0 ± 7.1% for CFS and control groups respectively), while 
at the three minute mark, MVC force production for the CFS group had increased by 8.5%, 
as compared to a slight increase of 1.2% for controls. By five minutes, MVC force 
production for the CFS group had increased a further 11.3%, while controls only 
experienced a 6% rise. During the last five minutes, only a slight increase of 0.8% was 
observed in the CFS group, as compared to a larger increase for controls of 4%. Final 
MVC values were 94.6 ± 11.9% for the CFS group and 84.0 ± 7.9% for controls. 
Differences between groups were not significant. 
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Figure 4.16. Normalised MVC force (means± SEM) for the CFS group (n = 6) and the 
control group (n = 6) recorded at 1, 3, 5 and 10 minutes during the recovery protocol. 
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4.4.5 MVC rmsEMG flw CFS and Control Oro ups During the Recovery Prolof!.!l 
Nonnaliscd MVC rmsEMG data produced a paltcrn very similar to MYC f(>rcc during 
recovery, with the major difTerencc heing that the control group demonstrated faster 
recovl!ry (Figure 4.17). Results between groups were nearly identical at the one and three 
minute mark, as represented by differences of 0.2% and 0.9% respectively. At the three 
minute mark, MVC rmsEMG in the control group began to recover at a faster rate as 
demonstrated by an increase of 16% and 5.4% between three and five minutes for the 
control and CFS groups respectively. From this point, amplitude recovered slowly in both 
groups reaching 79.1 ± 18.1% for controls and 69.8 ± 11% for the CFS group ten minutes 
post the fatiguing task. Independent t tests indicated no significant differences in results 
between groups. Due to the slower recovery evident in MVC nnsEMG as compared to 
MVC force recovery, paired t tests were perfonned on each group's baseline MVC 
rmsEMG and the value elicited ten minutes into recovery. Results demonstrated significant 
differences between these values for both groups (P < 0.05), suggesting that fatiguing 
processes were still occurring in the reference ann of all subjects. 
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Figure 4.17. Normalised MVC rmsEMG (means± SEM) for the CFS group (n = 5) and 
the control group (n = 6) recorded at 1, 3, 5 and 10 minutes during the recovery protocol. # 
denotes significant difference (P < 0.05) demonstrated by paired t tests between each 
group's baseline MVC rmsEMG and MVC rmsEMG elicited ten minutes post recovery. 
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5.1 Introduction 
CHAPTER FIVE 
I>ISCIISS!ON 
CFS represents a debilitating disorder that elicits feelings of despair and frustration in both 
sufferers and investigators alike. Attempts to solve the mystery surrounding its aetiology 
have involved intensive studies in recent years without the benefit of conclusive results. 
The search for answers has regularly involved the investigation of the fatigue that typifies 
the condition, with many studies noting that during exercise, CFS subjects often report 
fatigue as being associated with an increased gain in effort sensation. This study employed 
a fatiguing contralateral limbwmatching task in order to determine if sense of effort was 
altered in CFS subjects as compared to control subjects. Evidence of an abnormal sense of 
effort in CFS subjects may imply an association between central mediators for effort 
sensation and the fatigue that characterises CFS. Assessing the extent of central fatigue 
during a fatiguing task is pertinent, in that central fatigue may promote sense of effort via 
impaired neural drive. In order to assess the development of central fatigue in CFS 
subjects, all subjects were requested to perform regular MVC's over the course of a 
fatiguing task. Four hypotheses were formulated in anticipation of outcomes for these 
tasks, with each one addressed separately in this discussion. Finally. the conclusion 
presents an overview of findings, as well as offers suggestions for further research related 
to the area of investigation in this study. 
5.2 Central Fatigue and Sense of Effort 
The first hypothesis postulated that CFS subjects would show a greater decline in maximal 
force during the fatiguing task when compared to control subjects. Results for nonnalised 
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iutcnnittcnt MVC produced during the J:ttiguing task inJicatcd no significant dif1Crence 
between groups. resulting in the rejection of this hypothesis. 
Evaluating the ability to pcrthrm an MVC over the course of a J3tiguing task may assist in 
determining the existence and development of central fatigue. AccorJing to Kent-Braun ct 
al. ( !993, p. 130), absence of a peripheral basis for fatigue, combined with the inability to 
fully activate skeletal muscle during maximal exercise "suggests a major role of central 
factors in the fatigue in CFS". Central fatigue, which is defined by an impaired 
motoneurone drive (Stokes et al. 1988), may contribute to a greater sense of effort by 
promoting a disproportionate mismatch between afferent and efferent signals, resulting in 
recalibration of the corollary discharge. This recalibration process is pertinent in that sense 
of effort is postulated to result from attention to the amplitude of the corollary discharge. 
While CFS and control subjects may be able to produce similar MVC's when the exercising 
muscle is fresh (unfatigued), this ability is tested in CFS subjects, as fatigue develops, by 
the possible emergence of certain psychological factors that can promote central fatigue. 
Psychological factors, exemplified by boredom and intolerance to pain, may lead to loss of 
motivation (Wessely & Edwards, 1993), as well as induce increased inhibition or reduced 
facilitation (Miller et al. 1996). As a psychological aetiology is often proposed for CFS 
(Wessely & Edwards, 1993), these factors may be more prevalent in CFS subjects than in 
controls, consequently resulting in larger decrements in MVC force by CFS subjects. 
Interestingly, not only was there no significant difference in results between groups in 
MVC force and MVC nnsEMG, comparison of normalised means demonstrated that the 
decline in MVC force was greater in the control group (38%) than in the CFS group (34%). 
Furthennore, results for MVC force between groups during recovery, while not statistically 
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significant, demonstrated a lltster recovery in maximal lOree fOr the CFS group (94% of 
initial MVC) as compared to controls (84% ofinitial MVC). 
Absence of an objective measure tOr maximal voluntary contractions, such as twitch 
interpolation, makes it difficult to confirm inferences. However, the similar MVC 
fatigability and recovery demonstrated between CFS and control subjects in this study, 
suggests that excessive central fatigue did not occur in CFS subjects. These results support 
research by Lloyd et al. (1988, 1991) and Wesse!y and Edwards (1993), that documented 
normal MVC capabilities in CFS subjects in the fresh and unfatigucd states. Similar 
muscle function demonstrated between CFS and control subjects, further suggests that 
metabolic changes in the exercising muscle were not occurring excessively or prematurely 
in CFS subjects. 
5.3 Matching Force Production During the Fatiguing Task. 
The second hypothesis in this study staled that CFS subjects would exhibit increased force 
production in the matching limb during the fatiguing task, when compared to control 
subjects. Statistical analysis of results demonstrated no significant difference in matching 
force production between groups, resulting in the rejection of this hypothesis. While the 
results did not demonstrate statistical significance, comparison of normalised means 
confirmed that the CFS group produced consistently larger matches for each respective 
time interval, when compared to controls. Differences in matching force between groups 
increased from 4% to 7% during the last five minutes of the task. This trend implies that a 
more pronounced difference in matching force between groups may have resulted if the 
fatiguing task had continued for a longer duration. Increased matching force during a 
fatiguing contralateral limb matching task exemplifies attention to mediators for sense of 
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etlbrt rather than the reference force (Cafhrclli, 1988; Jones, 1995; McCloskey, l97H). 
Factors that may contribute to an increased sense of eff<lrt in CFS arc discussed in section 
5.5. 
Attempts to accurately match the reference force of 30% proved unsuccessful during the 
early stages of the fatiguing task for both groups. It was only at the 40th minute mark that 
the CFS group successfully matched the reference force of 30%, while the control group 
did not match the reference force until the 45th minute. These results differ to studies 
reported by McCloskey et al. (1983), and Jones and Hunter (1983a) who demonstrated that 
subjects could accurately match the reference force during the early stages of the exercise 
when muscles were fresh (unfatigued). The discrepancy between findings in this study and 
those reported above, may relate to variations in subjects, equipment and protocol, as well 
as subject's familiarity with the protocol. 
5.4 Reference rmsEMG Amplitude During the Fatiguing Task 
The third hypothesis in this study postulated that CFS subjects would demonstrate greater 
reference nnsEMG amplitude during the fatiguing task, when compared to control subjects. 
Statistical analysis of results indicated no significant difference between groups for 
reference nnsEMG amplitude, resulting in the rejection of this hypothesis. 
EMG amplitude represents an indirect measure of the final efferent input into a muscle and 
has been documented to increase steadily with fatigue in order to compensate for the loss of 
tension that occurs in fatigued motor units (Beliveau et al. 1992). Jn relation to 
contralateral limb matching tasks, Jones and Hunter (1983b) note that EMG amplitude of 
the reference limb parallels the change in perceived force, as measured by a matching 
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contraction in the unfatigued limb. This study supports theses lindings as rciCrcncc 
m1sEMG and force in the matching limb were found to be highly correlated during the 
fatiguing task for both the CFS group (r '-"""' 0.88) and the control group (r == 0.96) 
respectively. As the second hypothesis postulated that CFS subjects would produce a 
greater match during a fatiguing task when compared to control subjects, it was implied 
that matching and reference nnsEMG amplitude would also be higher in CFS subjects as a 
result of an associated greater sense of effort. The inability to substantiate a greater sense 
of effort in CFS subjects in statistical terms (refer to section 5.3), would support the 
rejection of this third hypothesis. 
Comparison of normalised means between groups for reference nnsEMG confirmed higher 
amplitude in the CFS group during the last ten minutes of the task, which resulted in a 5% 
difference between groups. This enhanced neural drive, although not statistically 
significant, implies that a more fatiguing protocol may have resulted in a significantly 
higher reference rrnsEMG in CFS subjects relative to controls. Support for this trend is 
provided by the elevated RPE scores reported toward the end of the fatiguing protocol by 
CFS subjects, that equated the effort as being between 'almost maximal' and 'maximal', 
subjectively demonstrating the escalating magnitude of the effort associated with the task 
for this group. While there was no significant difference in reference nnsEMG between 
groups during recovery, results were slightly higher in the CFS group, most likely 
reflecting an extension of the increased amplitude recorded by this group at the conclusion 
of the fatiguing task. 
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5.5 Sense of EITort During, the Fatiguing Task. 
The linal hypothesis in this study stated that CFS subjects would report higher levels of' 
perceived exertion from a CR-10 scale during the fatiguing task, when compared to 
controls. Analysis of individual RPE scores during the fatiguing task indicated that CFS 
subjects reported signilicantly higher RPE scores than control subjects. These results 
consequently support this last hypothesis. 
Elevated RPE scores have been reported by CFS subjects during exercise in many studies 
(Gibson et al. 1993; Riley et al. 1990: Rowbottom, Keast, Pervan & Morton, 1998; Sisto et 
al. 1996), suggesting that CFS subjects associate similar levels of exercise with a greater 
sense of effort than controls. An important consideration relates to whether the higher RPE 
scores reported by CFS subjects during exercise reflect a greater sense of effort associated 
with the exercise or augmented pre~exercise values. Existence of a greater sense of effort 
in CFS subjects rrior to exercise has been postulated in studies by Edwards et al. (1991), as 
a result of elevated RPE scores reported by CFS subjects at the commencement of exercise. 
Further studies by Gibson et al. (1993, p. 997), noted that the higher RPE scores reported 
by CFS subjects during an incremental cycle exercise, most likely reflected "CFS patients 
'adding on' the subjective fatigue felt at rest to their effort scores during exercise". While 
this conclusion was speculative in that no pre-exercise RPE scores were recorded, results 
from this study support this conjecture. Baseline RPE scores reported in this study were 
significantly higher in CFS subjects when compared to control subjects (P ,; 0.005), 
suggesting that scores given during the fatiguing exercise represented an extension of these 
initial values. According to Gibson et al. (1993), elevated RPE scores reported by CFS 
subjects at the commencement of exercise would preclude the involvement of metabolic or 
electrophysiological factors that are associated with peripheral fatigue. 
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An abnonnal sense of effort experienced prior to exercise was also reflected by responses 
given to a POMS questionnaire recorded prior to testing. T{csults demonstrated CFS 
subjects reporting significantly higher levels of subjective fatigue (P ~ 0.000 I) associated 
with lower levels of vigour (P ""= 0.001 ), when compared to controls. 
Wessely and Edwards ( 1993) suggest that the abnormal sense of effort reported by CFS 
patients in their studies may reflect a disproportionate mismatch between afferent feedback 
and efferent feedforward signals. In chapter two, it was postulated that a mismatch 
between afferent and efferent feedforward (corollary discharges) signals could result in the 
recalibration of the corollary discharge, with sense of effort detennined by the resulting 
amplitude of this signal. Therefore a larger than nonnal (disproportionate) mismatch 
between afferent and efferent signals should result in greater amplitude of the corollary 
discharge and a simultaneous 'gain' in effort sense. A disproportionate mismatch between 
neural signals, as a result of augmented or attenuated afferent or efferent signals, may occur 
for a number of reasons, with overlap between physiological and psychological factors 
often evident. 
Central fatigue and sense of effort are intrinsically linked in that mediators for central 
fatigue are reflected by a reduced motoneurone drive, with a concomitant influence on 
effort sense. Central fatigue can be induced or augmented by the triggering or 
amplification of relevant psychological symptoms such as apprehension or anxiety, which 
according to Miller et al. (1996), can result in the habitual inhibition of motor unit 
recruitment. Triggering or amplification of psychological mediators for central fatigue can 
be a consequence of the heightened sensitivity to physiological function that may occur 
when CFS patients vigilantly monitor thf"se sensations in an attempt to control and reduce 
SR 
symptoms (Wcssl•ly & Edwards, 1993). The likelihood of'exce:-;sive mediators f{Jr central 
Httiguc occurring in CFS subjects in this study (and theref(Jre contributing to H 
disproportionate mismatch between neural signals in these subjects) arc unlikely due to the 
similar muscle flmction demonstrated during the lhtiguing task between the CFS and 
control groups. 
As well as contributing to central fatigue, heightened attention to physiological mediators, 
such as one's heartbeat or ventilation, can amplify the existence of these functions, thereby 
augmenting afferent tCedback (Wessely & Edwards, I 993). Heightened sensitivity can 
further intensify the sensation of pain often reported in CFS, possibly triggering 
psychological and motor inhibitory responses aimed at its avoidance (McClusky, 1993). As 
excessive occurrence of mediators for central fatigue was not established in CFS subjects 
during this study relative to controls, it is possible that a heightened sensitivity to sensory 
feedback took place in CFS subjects, consequently elevating their sense of effort. 
A disproportionate mismatch between neural signals may be a consequence of loss of 
automatic functioning (Lawrie et al. 1997). Lawrie et al. have suggested that under normal 
circumstances, common activities evoke a preconceivrd motor command that is analogous 
to automati~. functioning, with calibration between afferent and efferent signals usually 
being unnecessary or minimal. Lawrie et a!. (1997) continue to suggest that automatic 
functioning may be impaired in CPS patients due to transient disturbances in the higher 
executive functions of the CNS as a result of disease. This situation is further compounded 
by lack of appropriate practice of skilled activity, resulting in the need for CFS patients to 
devote more attention to both motor and somatosensory feedback during activity (Edwards, 
1992). Slow and deliberate movement, which deprives patients of the learned automaticity 
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of the motur skill. exempli lies this process (l~dwards, 1992). 'l'hc switch Ji·om automatic 
functioning to attention JOcusing may promote heightened scnsilivity, resulting in a g<.~in in 
atTercnt inllow and a consequent increase in effort scnS!.!. The need fi)r greater attention to 
movement, as well as to cognitive tasks, was described by all CFS subjects in this study. 
Loss of automatic functioning may occur as a result of deconditioning. Dcconditioning 
otlen occurs in CFS in response to long periods of inactivity taken by these patients in an 
etTort to reduce symptoms. As well as increasing the likelihood and severity of the delayed 
onset of muscle soreness when normal activity is resumed, deconditioning can alter the 
subjective difficulty of a task (Jain & DeLisa, 1998). Activity that once was aerobic 
becomes anaerobic through deconditioning, with consequent decreases in plasma and 
muscle pH being monitored by the sensory cortex via increased afferent feedback, resulting 
in a gain in effort sense. Deconditioning can also promote psychological responses such as 
apprehension and anxiety regarding activity, with a possible motor inhibitory response 
reducing neural drive (Wcssely & Edwards, 1993). While all CFS subjects in this study 
reported long periods of inactivity associated with their disorder, the degree of 
deconditioning (and consequent afferent feedback), is dependent on the time duration of 
this inactivity, activity levels prior to the on::.:et ofCFS, as well as subsequent exercise. The 
level of deconditioning, if in existence, will therefore be varied in each subject. 
Assessment of aerobic capacity prior to testing may lead to a more informed assessment of 
subjective levels of deconditioning, as well as assist in the appropriate matching of controls 
with CFS subjects. 
Increased afferent feedback and consequent gain in effort sense may also be related to the 
presence of a low-grade infections, noted by Gibson et al. (I 993) to be evident in 53% of 
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patients diagnosed with post viral fatigue syndrome (a subset ofCFS). As all CFS subjects 
in this study had their disorder triggered by an infCction, ~he presence of low-grade 
infections may have contributed to an abnormal sense of effort in these subjects. 
A gain in eftbrt sense as a consequent of a disproportionate mismatch between neural 
signals, may be further amplified by a lower sensory threshold in CFS patients (Gibson ct 
al. 1993), as well as an increased detection threshold for force (Jones, 1995). A lowered 
sensory threshold implies that attention to the amplitude of the corollary discharge may 
occur earlier in CFS subjects relative to controls, while an increased detection threshold for 
force suggests that CFS subjects detect force earlier than controls with a concomitant 
increase in afferent feedback. Gibson et al. (1993, p. 997) suggest that the resetting of the 
sensory threshold "may be a learned response to stimuli no longer present," while an 
increased detection threshold has been demonstrated during prolonged exposure to 
fatiguing sounds, as well as to visual and olfactory stimuli (Jones, 1995). 
5.6 Conclusion 
This study demonstrated that force and rmsEMG were not statistically different between 
CFS and control subjects during a fatiguing contralateral limb matching task. However, 
comparison of normalised mean matching forces for each time interval during the fatiguing 
task, confirmed that the CFS group produced greater force than controls when attempting to 
match a low-level isometric force of the reference arm. This increased matching force, 
which was most noticeable in the last five minutes of the protocol, was paralleled by 
matching nnsEMG activity, as well as higher nnsEMG in the reference ann of CFS 
subjects. These trends suggest that a more fatiguing protocol or a larger cohort may have 
produced statistically significant results. Overestimation of matching force during a 
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contralateral limb matching task ohjcctivcly demonstrates attention to central mediators liJr 
sense ofell'ort. While increased matching f(Jrcc with a concomitant increase in emJrt sense 
in the CFS group relative to the control group were not statistically supported, a greater 
sense of effort was subjectively confirmed by signilicantly higher RPE scores reported by 
the CFS group, both prior to and during exercise. 
Elevated RPE scores reported prior to exercise suggest that peripheral fatigue is unlikely to 
account for the btigue experienced in CFS, while normal MVC values (as demonstrated by 
comparison to contrp,·.;) r.,·.:··ludes excessive and premature central mediators for fatigue. 
Normal muscle physiology evident in CFS subjects would imply that the regular 
application of a neurophysiological definition to the fatigue experienced in this disorder 
may be inappropriate and need reassessing. Possibly, central mediators for sense of effort 
may better define the fatigue experienced in CFS. 
Improvements to research in the area investigated in this study, include the following: 
Larger cohorts would produce results that are more representative of the population. 
2 Testing of CFS subjects whose condition was triggered by factors other than :m 
infectious episode. This would test to see if all CFS subsets responded to a 
fatiguing task in the same manner. 
3 Recording and correlation of RPE values and POMS responses during recovery. 
This would provide insight into the fatigue experienced by CFS subjects after 
exercise, as well as detennine if any association exists between these two 
parameters. 
4 Employment of twitch interpolation techniques in order to provide for objective 
determination of the attainment ofMVC in all subjects. 
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5 Employment of a more littiguing task. A task that promotes greater lhtiguc m<Jy 
validate trends. The task can be made more fittiguing by increasing the length of '~JC 
protocol by five to ten minutes, by reducing rest periods from three seconds to two, 
or by increasing the rciCrcnce force. Stevens and Cain (1970) note that cffi:>rt 
relating to constant force contractions increases with time at a rate dependent on the 
level of the rcfCrencc force. 
6 Employment of a scale that measures su~jective levels of pain. Usc of such a scale 
during a fa!;~uing task, would indicate if CFS subjects were experiencing greater 
levels of pain than controls. Higher pain levels may induce central fatigue or 
amplify afferent feedback, resulting in a consequent gain in effort sense. 
7 Employment of a questionnaire concemed with activity level prior to onset of CFS, 
as well as the time period of any inactivity. This information will assist in 
determining the impact of deconditioning on effort sense. 
8 Assessment of aerobic capacity prior to testing will assist in assessing subjective 
levels of deconditioning, as well as aid in appropriately matching controls with CFS 
subjecb. 
CFS represents a topical syndrome that in recent times has featured regularly in newspaper 
and magazine articles. More often than not, reference is made to the elite sportsperson 
whose career has suffered as a consequence of the disorder. Rarely mentioned are the 
numerous 'ordinary' people whose lives have suffered dramatically as a result of this 
debilitating illness. Lack of consensus regarding aetiology, combined with dissension 
concerning the origin of the fatigue that typifies the disorder, present a strong case for 
further research in this field. 
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Criteria for diagnosis for chronic fatigue syndrome (Jain &DeLisa, 1998) 
..-:;--;--;;-;:--~----,.-;;o---~;:--cc------ --- ----c-------- ·---
Major Criteria's Minar Criteria Physical Signs 
tboth must be pn:sent) (at least 8 symptoms and 2 
signs} 
l. Onset of persistent or Infectious: 
relapsing, debilitating fatigue Mild rever of chills 
in a person without a previous 
history of such symptoms, Sore throat: 
that does not resolve with bed Painful adenopathy 
rest and is severe enough to 
significantly reduce daily Rheumatologic: 
activity for at least 6 months. Unexplained, generalised muscle 
weakness 
2. Fatigue that lS not Myalgias, migratory arthalgia, 
explained by the present of without swelling or erythremia 
other evident medical or Prolonged generalised fatigue 
psychiatric illness. after previously tolerated 
physical activity 
Migratory arthralgia without 
swelling or redness 
Neuropsychologic 
Recurrent generalised headache~ 
depression 
Sleep disturbances 
Impaired cognition 
Anxiety 
Photophobia 
Transient scotoma 
Main symptom complex 
Developing over a few hours to 
a few days 
Low-grade fever 
Noncxudativc pharyngitis 
Palpable or tender anterior 
or posterior cervical or 
axillary lymph nodes. 
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Consent Form for 11articipation in the Investigation into 
>~Sense of 11:ffort Assuci11tell with l1'atigue in Chronic Fntiguc Syndrome t•~•ticnt~" 
The purpose oftbis study is to investigate the sense or cfl(lrt cxrcricm:cd hy Chronic Fatigue 
Syndrome subjects when pcr!Ormmg a prolonged sub-maximal intermittent contraction. 
We will test the strength or your elbow flexor muscles by asking you to perform a brief 
maximal static contraction. You will then be asked to hold a light contraction intermittently 
for 45 minutes. At this point the exercise will be terminated. During the contraction, you will 
be asked to match the force in the non-dominant arm with your dominant ann fOr a period of 
7 seconds every minute. We will also ask you to rate your perceived effort on a number scale. 
Throughout this procedure, the electrical activity (EMG) generated by your muscles will be 
monitored using surface pads. 
The above protocol will be clearly demonstrated and you will have a chance to practice before 
the testing commences. Some slight delayed soreness may be experienced in the exercised 
arm 24-48 hours after the testing day, similar to that which you might experience when you 
first exercise after a break. Subjects with Chronic Fatigue Syndrome may experience 
increased tiredness after performing the exercise. 
The results gained fi·om this research may be used to further our insight into how sense of 
effort is altered when our muscles are fatigued. 
Having read the above statements, I acknowledge that I am able to withdraw from the study at 
any time and am aware of the possible side effects that may occur. I also release Edith Cowan 
University and the Australian Neuromuscular Research Institute from any claim arising from 
experimental procedures. 
For further infonnation please contact either Mrs K. Wallman on  or Dr. P. Sacco 
on . 
I ............................................... , aged ............... years, agree to participate as a 
subject in the above study. 
Signed ..................................................... . Date ............................. .. 
Witnessed .................................................. . Date ............................... 75 
Appendix C 
Activity Sheet 
76 
Personal Activity Sheet 
NAME: .............................. .. SUBURB: ................................ . 
CONTACT PHONE NO: ........................ . 
CONVENIENT CONTACT TIME: ....................................................... . 
AGE: ............ . HEIGHT: ............ .. WEIGHT: .............. . 
Please complete the following record of you average weekly exercise participation. This refCrs to 
specific exercise such as walking and fitness classes as opposed to exercise that occurs due to 
shopping, work around the house, etc. Please circle the number closest to the correct response. 
Frequency 5 Daily or almost daily 
4 3 to 5 times per week 
3 1 to 2 times per week 
2 A few times per month 
Less than once per month 
Intensity 5 Sustained heavy breathing and perspiration (extremely hard) 
4 Heavy breathing and perspiration (moderate to hard) 
3 Moderately heavy breathing as in brisk walking (moderate) 
2 Moderately heavy breathing as in casual walking (light/moderate) 
1 Very easy as in stretching (light) 
Time 4 Over 30 minutes 
3 20 to 30 minutes 
2 10 to 20 minutes 
1 Under 10 minutes 
Do you do any upper body work? If yes give details of how often per week .................... .. 
77 
Oflkc lnf(mnation Only 
Subjects arc classilicd by multiplying frequency x intensity x time. 
General classification 
5-25 
25-55 
55-100 
Sedentary 
Moderate 
Hit;;hly active 
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Appendix I) 
Medical Questionnaire 
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Medical History Question nair£ 
This is to establish a bnckground for your personal health and any recent or current injuries or 
illnesses that may afTcct your testing or pcriOrmancc. Please answer questions as accurately as 
possible. All infonnation is strictly conlidcntial. 
Name: 
Sex (please tick) Male Female ____ _ 
Age: __ _ Weight: __ _ Best/desired weight: 
Name of Family Doctor: 
Address of Family Doctor: 
Phone No. of Family Doctor: 
Name for Emergency Contact: 
Emergency Contact's phone no.: 
Do you currently have or have had any of the following? 
(Please Circle) 
High or abnormal blood pressure y N 
High cholesterol/triglycerides y N 
Rheumatic fever y N 
Any known abnormal heart condition y N 
Asthma y N 
Diabetes y N 
Back pain y N 
80 
N~ck pain y N 
Allergies y N 
Hav~.: you rCCL'Otly had any infectious diseases (include nu)'! y N 
Arc you pregnant? y N 
Arc you taking Beta -blocker drugs? y N 
Are you taking any other drugs/medication y N 
Arc you on? special diet? y N 
Is there any other condition not mentioned that may 
affect your activities? y N 
If you answered yes to any of the above questions, please give more details in the space provided 
below. 
Have you experienced any of the following? 
Any recent injuries, accidents or illnesses? 
Any recurring muscular pains/cramps? 
y 
y 
N 
N 
If you answered yes to either of these questions, please give more details in the space provided. 
Rl 
Family History 
Are any of the tbllowing known to exist in your family? 
Cardiac disease 
Pulmonary disease 
Stroke 
Sudden death (unexplained) 
Lifestyle Habits 
Do you exercise nJgularly? 
If yes, how many minutes of medium to high intensity exercise per 
week? 
Do you smoke tobacco or any other nicotine products? 
If you answered No and were once a smoker, how long since 
quitting? 
Do you consume alcohol? 
How many standard drinks per week? 
Do you consume tea and/or coffee? 
How many cups per day? 
Do you take recreational (steroid/party) drugs? 
How often/much per week? 
y 
y 
y 
y 
y 
y 
y 
y 
y 
N 
N 
N 
N 
N 
N 
N 
N 
N 
Should any obvious physical signs of distress occur during testing, the session 
will be terminated 
Appendix E 
POMS Questionnaire 
RJ 
r 
) 
••• 
NAME-- ------------ DATE _____ _ 
SEX: Male@ Female 0 
Below is a list of words that describe feelings people have. Please read each one 
carefully. Then fill in ONE circle under the answer to the right which best describes 
HOW YOU HAVE BEEN FEELING DURING THE PAST WEEK INCLUDING TODAY. 
The numbers refer to these phrases. 
0 = Not at all ~ ... .. w 
1 = A little ... .. iii < w < 
2 = Moderately .. ... CZ: < < ~ IU IU .. 0 .. 3 = Quite a bit :; 5 0 0 
z < :E 0 
~ 
w 
:E 
IU 
CZ: 
.. 
>< 
w 
4 = Extremely 
21 . Hopeless . .... .®0@©© 
,.. 
... .. ,.. :::l w .. iii ... < IU < w 
.. ~ CZ: < :E < IU IU w .. 0 .. CZ: :; 5 .. 0 0 )( 
z < :E 0 IU 
45. Desperate . ... . . .®0@©© 
Col@ O.P.@) 22. Relaxed .. . ..... ®0@©© 46. Sluggish .. . ....... ®0@©© 
:::l ~ .. ~ 23. Unworthy ...•... ®0@@© 47. Rebellious ......... ©0@@© 
< ~ m "' ~ § j j i 24. Spiteful ........ ®0@©© 48. Helpless ...... .. . . ©0@@© 
Z < ::t O u., 
1. Friendly .. . ..... ®0@@© 25. Sympathetic ..... ®0@@© 49. Weary ...... . .... ®0@@© 
2. Tense ......... ® 0@© © 26. Uneasy . . ....... ® 0@@© 50. Bewildered . . ...• .. ® 0@@© 
3. Angry ......... ®0@@G) 27. Restless ........ ®0@@© 51. Alert ............ ®0@@© 
4. Worn out .. ..... ® 0@@© 28. Unable to concentrate ® ©@@© 52. Deceived ........ . ® 0@@0 
5. Unhappy . . •.... . ®0@@G) 29. Fatigued ........ ®©@©0 53. Furious .......... ®0@@0 
6. Clear-headed ..... ®0@@© 30. Helpful ..... . .. . ®0@©0 54. Efficient . .. . .... . . ®0@@0 
7. Lively ...•..... . ®0@@© 31. Annoyed ....... . ®0@@© 55. Trusting .......... ®0@@© 
8. Confused . ..... . ® ©@@0 32. Discouraged . .... ® ©@@© 56. Full of pep ........ ® 0@@0 
9. Sorryforthingsdone .®0@@© · 33. Resentful ....... ®0@00 57. Bad-tempered ... . .. ®0@@0 
10. Shaky ......... ®0@@© 34. Nervous .....•.. ®0@@G) 58. Worthless .... . .. . . ©0@@G) 
11. Listless ......... ®~@00 35. Lonely ......... ®0@0© 59. Forgetful ......... ®0@@0 
12. Peeved ......... ®0@@0 36. Miserable •...... ®0@0© 60. Carefree ..... . .... ®0@@© 
13. Considerate ..... . ®0@@© 37. Muddled •... . . . . ®©@@G) 61 . Terrified .......... ®0@@0 
14. Sad ......... . . ®0@@G) 38. Cheerful ..... . .. ®©@0© 62. Guilty . .. . ....... ®0@@0 
: 15. Active ......... @©©@© 39. Bitter .......... ©©@©© 63. Vigorous . . ........ @©©@© 
16. On edge ...... .. ® 0@0 0 40. Exhausted ....... ® ©@0 0 64. Uncertain about things .. ® 0@@0 
17. Grouchy ........ @0@@© 41. Anxious .... . . .. ®©@@0 65. Bushed .......... ®0@@0 
18. Blue .......... ®©@0© 42. Ready to fight .... ®0@0© 
19. Energetic ....... ®©@©© 43. Good natured ..... ®©@@0 
20. Panicky ........ ®0@©© 44. Gloomy ....... . ®©@00 
MAKE SURE YOU HAVE 
ANSWERED EVERY ITEM. 
e PO M 021 
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Appendix F 
Calibration Details 
Appendix F 
Linear Regression for Calibration of Strain Gauge. 
..... 
::J 
a. 
..... 
::J 
0 
400 
300 
a> 200 0) 
::J 
rn 
C) 
C 
~ 
u5 100 ------,(.~--------..-----,,,-------,..-----=--------.! 
.5 1.0 ·1.5 
Calibration plates 
• \ 
2.0 2.5 3.0 3.5 4.0 4 .5 
(Newtons) 
Calibration of strain gauge using fixed plates (N). Each fixed plate weighed 11.34 kg, 
(111.245 N) .. 
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Appendix G 
RPE Data Collection Sheet 
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RPE Data Information Table 
Subject No: ............................... . 
Age .......... . 
MVC (Dominant Arm) 
(Note whether lcfi or right is dominant arm) 
Non Dominant Arm 
70% 
50% 
30% 
Time 
(mins) 
I 
2 
3 
4 
5 
6 
7 
8 
9 
10 
II 
12 
13 
14 
IS 
16 
17 
18 
19 
20 
21 
22 
23 
24 
RPE Comments 
Weight ............. . 
MVC (Non Dominant Arm) ....... . 
Dominant Arm 
70% 
50% 
30% 
Time 
(mins) 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
R-1 
R-3 
R-5 
R-IO 
RPE Comments 
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Appendix H 
Cr-10 Scale 
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CR-10 Scale 
0 - Nothing at all 
0.5 - Very, very weak Gust noticeable) 
1 - Very weak 
2 - Weak (light) 
3 - Moderate 
4 Somewhat strong 
5 Strong (heavy) 
6 
7 - Very strong 
8 
9 
10 - Very, very strong (almost max) 
0 
- Maximal 
Source: Borg, G. (1982). Psychological bases of perceived exertion. Medicine and 
Science in Sports and Exercise, 14 (5), 377-381. 
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Appendix I 
Results for Pilot Study 
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Pilot Study 
Su\:lject 1 Subject 2 Subject 3 Subject4 Sybject 5 
Jest 1 Test 2 Test 1 Jest 2 Test 1 Test 2 Jest 1 Test~ Test 1. I~!1. 
Averaged Force RecorUio~in Left Arm {newtons) 
MVC (best) 238 241 314 318 310 324 471 415 4::14 373 
80% ofMVC 185 191 244 257 242 270 361 334 351 292 
60% of MVC 142 138 180 192 180 200 285 242 251 222 
40% ofMVC 92 88 124 131 123 136 184 168 175 152 
20% ofMVC 47 45 60 65 59 71 94 86 89 76 
Averaged Force recording in Right Arm !newtons) 
MVC (Best) 229 242 370 360 319 344 341 342 363 372 
80% ofMVC 183 195 293 295 249 275 273 265 294 285 
60% ofMVC 137 145 221 218 194 210 208 206 176 186 
40% orMVC 91 99 148 145 127 140 140 135 151 152 
20% orMVC 47 49 71 73 64 70 92 75 76 69 
Averaged EMG Recording in Left Arm 
MVC (best) 0.180 0.133 0.121 0.168 0.389 0.325 0.278 0.303 0.283 0.276 
80% ofMVC 0.136 0.096 0.100 0.146 0.227 0.209 0.200 0.236 0.158 0.135 
60% ofMVC 0.092 0.093 0.088 0.133 0.184 0.125 0.165 0.192 0.060 0.072 
40% ofMVC 0.089 0.048 0.085 0.059 0.081 0.078 0.078 0.100 0.047 0.060 
20% ofMVC 0.050 0.038 0.048 0.045 0.075 0.037 0.048 0.045 0.028 0.021 
Averaged EMG Recording in Right Ann 
MVC (best) 0.169 0.138 0.248 0.273 0.281 0.300 0.219 0.210 0.183 0.210 
80% ofMVC 0.132 0.120 0.190 0.232 0.153 0.142 0.196 0.152 0.157 0.188 
60% ofMVC 0.083 0.076 0.136 0.186 0.132 0.094 0.137 0.149 0.073 0.140 
40% ofMVC 0.064 0.054 0.102 0.122 0.077 0.062 0.074 0.102 0.071 0.086 
20% ofMVC 0.030 0.028 0.020 0.026 0.025 0.036 0.039 0.037 0.035 0.052 
92 
PILOT STUDY 
Statistics for 80% MVC 
80% MVC • Force -Left Arm 80% MVC • Force -Right Ann 
Test 1 Test 2 Difference Test 1 Test 2 Difference 
Subject 1 185 191 -6 163 195 -12 
Subject 2 244 257 -13 293 295 -2 
Subject 3 242 270 -28 249 275 -28 
Subject4 361 334 27 273 265 8 
Subject 5 351 292 59 294 285 9 
Mean 276.60 268.80 7.80 256.40 263.00 -4.60 
SD 76.34 52.40 34.98 45.97 39,62 14.69 
Method Error* 24.74 10.39 
Coefficient 
Variation (%) 9.1 3.6 
Correlation 0.92 0.95 
Squared Correlation Coefficient(%) 64 91 
80% MVC • EMG - left Ann 80% MVC- EMG- Right Ann 
Test 1 Test 2 Difference Test 1 Test 2 Difference 
Subject 1 0.136 0.096 0.04 0.132 0.120 0.012 
Subject 2 0.100 0.146 -0.046 0.190 0.232 -0.042 
Subject 3 0.227 0.209 0.016 0.152 0.142 0.01 
Subject 4 0.200 0.236 -0.036 0.196 0.152 0.044 
Subject 5 0.156 0.135 0.023 0.157 0.188 -0.031 
Mean 0. !C-4 0.164 0.000 0.165 0.167 -0.001 
SD V.050 0.057 0.038 0.027 0.044 0.035 
Method Erro. • 0.027 0.025 
Coefficient 
Variation(%) 16.5 14,9 
Correlation 0.75 0.61 
Squared Correlation Coefficient(%) 57 37 
• Method Error formula from Thorstensson, 1976 (cited in MacDougall, Wenger & Green, 
1991, p, 76). 
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PILOT STUDY 
Statistics for 40% MVC 
40% MVC - Force ·Left Arm 40% MVC • Force ·Right Arm 
Test 1 Test 2 Difference Test 1 Test2 Difference 
Subject 1 92 88 4 Y1 99 -8 
Subject2 124 131 -7 148 145 3 
Subject 3 123 136 -13 127 140 -13 
Subject4 184 168 16 140 135 5 
Subject 5 175 152 23 151 152 -1 
Mean 139.60 135.00 4.60 131.40 134.20 -2.80 
so 38.76 30.02 15.11 24.42 20.66 7.56 
Method Error- 10.68 5.35 
Coefficient 
Variation(%) 7.8 3.5 
Correlation 0.93 0.96 
Squared Correlation Coefficient(%) 87 92 
40% MVC • EMG • Left Arm 40% MVC· EMG- Right Ann 
Test 1 Test2 Difference Test 1 Test2 Difference 
Subject 1 0.089 0.048 0.041 0.064 0.054 0.01 
Subject 2 0.085 0.059 0.026 0.102 0.122 -0.02 
Subject 3 0.081 O.D78 0.003 0.077 0.062 0.015 
Subject 4 0.078 0.100 -0.022 0.074 0.102 -0.028 
Subject 5 0.047 0.060 -0.013 0.071 0.086 -0.015 
Mean 0.076 0.069 0.007 0.078 0.085 -0.008 
so 0.017 0.020 0.026 0.014 0.028 0.019 
Method Error* 0.019 0.013 
Coefficient 
Variation(%) 25.7 16.5 
Correlation 0.004 0.78 
Squared Correlation Coefficient 0.001 61 
"Method Error fonnula from Thorstensson, 1976 (citad in MacDougall, Wenger & Green, 
1991, p. 76). 
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PILOT STUDY 
Statistics for 60% MVC 
60% MVC - Force -Left Arm 60% MVC - Force -Right Arm 
Test 1 Test2 Difference Test 1 Test 2 Difference 
Subject 1 142 138 4 137 145 -8 
Subject 2 180 192 -12 221 218 3 
Subject 3 180 200 -20 194 210 -16 
Subject 4 285 242 43 208 206 2 
Subject 5 251 222 29 176 186 -10 
Mean 207.60 198.80 8.80 187.20 193.00 -5.80 
so 58.53 39.21 26.75 32.66 29.31 8.14 
Method Error* 18.92 5.75 
Coefficient 
Variation{%) 9.3 3.2 
Correlation 0.93 0.97 
Squared Correlation Coefficient(%) 86 94 
60% MVC - EMG - Left Ann 60% MVC- EMG- Right Ann 
Test 1 Test2 Difference Test 1 Test2 Difference 
Subject 1 0.092 0.093 -0.001 0.083 0.076 0.007 
Subject 2 0.088 0.133 -0.045 0.136 0.186 -0.050 
Subject 3 0.184 0.125 0.059 0.132 0.094 0.038 
Subject4 0.165 0.192 -0.027 0.137 0.149 -0.012 
Subject 5 0.060 0.072 -0.012 0.073 0.140 -0.067 
Mean 0.118 0.123 -0.005 0.112 0.129 -0.017 
so 0.054 0.046 0.040 0.031 0.044 0.042 
Method Error* 0.028 0.030 
Coefficient 
Variation(%) 23.2 24.9 
Correlation 0.69 0.41 
Squared Correlation Coefficient 48 17 
*Method Errorfonnula from Thorstensson, 1976 (cited in MacDougall, Wenger & Green, 
1991' p. 76). 
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I 
PILOT STUDY 
Statistics for 20% MVC 
20% MVC - Force -Left Arm 20% MVC - Force -Right Arm 
Test1 Test2 Difference Test 1 Test 2 Difference 
Subject 1 47 45 2 47 49 -2 
Subject 2 60 65 -5 71 73 -2 
Subject 3 59 71 -12 64 70 -6 
Subject 4 94 86 8 92 75 17 
Subject 5 89 76 13 /6 69 7 
Mean 69.80 68.60 1.20 70.00 67.20 2.80 
SD 20.54 15.27 9.98 16.48 10.45 9.26 
Method Error- 7.06 6.55 
Coefficient 
Vari,..•jon (%) 10.2 9.0 
Correlation 0.89 0.86 
Se1uared Correlation Coefficient(%) 78 73 
20% MVC • EMG • Left Arm 20% MVC- EMG- Right Arm 
Test 1 Test2 Difference r.&.1 Test2 Pifference 
Subject 1 0.050 0.038 0.012 0.030 0.028 0.002 
Subject 2 0.048 0.045 0.003 0.020 0.026 -0.006 
Subject 3 0.075 0.037 0.038 0.025 0.036 -0.011 
Subject 4 0.048 0.045 0.003 0.039 0.037 0.002 
Subject 5 0.028 0.021 0.007 0.035 0.052 -0.017 
Mean 0.050 0.037 0.013 0.030 0.036 -0.006 
SD 0.017 0.010 0.015 0.008 0.010 0.008 
Method Error"' 0.010 0.006 
Coefficient 
Variation(%) 23.9 17.8 
Correlation 0.49 0.61 
Squared Correlation Coefficient 24 37 
• Method Errorfonnula from Thorstensson, 1976 (cited in MacDougall, Wenger & Green, 
1991' p. 76). 
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 Appendix .J 
Results for Formal Testing 
Rsw and Normalised Data & Statistical Results 
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Timl! RPE 
Baseline 
MVC 11 
70% a 
50% 7 
30% 3 
Endurance 
1 
2 
3 
4 
2 
2 
2 
2 
5 3 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
3 
3 
3 
3 
3 
3 
4 
4 
4 
4 
4 
5 
5 
5 
5 
6 
6 
6 
7 
25 7 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
48 
41 
42 
43 
44 
45 
Recovery 
1 
3 
5 
10 
7 
7 
8 
8 
8 
8 
8 
8 
8 
9 
9 
9 
9 
10 
10 
10 
10 
10 
10 
10 
Force 
Matching % 
262 100 
92 35 
76 29 
43 16 
28 
35 
35 
40 
52 
35 
24 
29 
38 
37 
50 
49 
52 
42 
62 
60 
48 
49 
48 
33 
51 
60 
71 
43 
35 
52 
45 
47 
48 
46 
47 
60 
55 
58 
84 
68 
36 
61 
65 
54 
11 
13 
13 
15 
20 
13 
9 
11 
15 
14 
19 
19 
20 
16 
24 
23 
18 
19 
18 
13 
19 
23 
27 
16 
13 
20 
17 
18 
18 
18 
18 
23 
21 
21 
24 
25 
14 
23 
25 
21 
~ 
Reference % 
234 100 
163 70 
117 50 
70 30 
65 
70 
69 
70 
69 
71 
70 
69 
70 
71 
69 
70 
70 
69 
70 
71 
70 
68 
69 
70 
71 
70 
71 
73 
71 
70 
71 
69 
70 
73 
71 
70 
69 
70 
71 
87 
70 
68 
71 
69 
26 
30 
29 
30 
29 
30 
30 
29 
30 
30 
29 
30 
30 
29 
30 
30 
30 
29 
29 
30 
30 
30 
30 
31 
30 
30 
30 
29 
30 
31 
30 
30 
29 
30 
30 
29 
30 
29 
30 
29 
.!i.MQ EMG 
Matching ~ Reference % 
0.2 100 0.191 100 
0.07 35 0.15 79 
0.05 25 0.11 58 
0.05 25 0.06 31 
0.024 
0.033 
0.023 
0.023 
0.025 
0.033 
0.035 
0.03 
0.029 
0.04 
0.036 
0.031 
0.035 
0.039 
0.04 
0.036 
0.033 
0.033 
0.034 
0.03 
0.026 
0.028 
0.038 
0.034 
0.052 
0.057 
0.036 
0.041 
0.044 
0.035 
0.044 
0.042 
0.038 
0.041 
0.039 
0.062 
0.051 
0.029 
0.03 
0.043 
12 
17 
12 
12 
13 
17 
18 
15 
15 
20 
18 
16 
18 
20 
20 
18 
17 
17 
17 
15 
13 
14 
19 
17 
26 
29 
18 
21 
22 
18 
22 
21 
19 
21 
20 
31 
26 
15 
15 
22 
0.039 
0.048 
0.044 
0.032 
0.032 
0.039 
0.033 
0.033 
0.042 
0.044 
0.05 
0.042 
0.032 
0.031 
0.038 
0.046 
0.045 
0.038 
0.038 
0.04 
0.036 
0.042 
0.049 
0.04 
0.036 
0.04 
0.04 
0.038 
0.044 
0.056 
0.039 
0.048 
0.049 
0.059 
0.055 
0.066 
0.033 
0.031 
0.035 
0.032 
20 
25 
23 
17 
17 
20 
17 
17 
22 
23 
26 
22 
17 
16 
20 
24 
24 
20 
20 
21 
20 
22 
26 
21 
19 
21 
21 
20 
23 
30 
20 
25 
26 
31 
29 
35 
17 
16 
18 
17 
98 
Baseline 
MVC 
70% 
50% 
30% 
Endurance 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
11 
8 
6 
3 
3 
3 
4 
4 
4 
4 
5 
5 
5 
6 
6 
7 
6 
6 
7 
7 
7 
7 
7 
20 8 
21 
22 
23 
24 
25 
26 
27 
28 
29 
8 
8 
8 
8 
8 
8 
8 
8 
8.5 
30 8.5 
31 
32 
33 
34 
35 
38 
37 
38 
39 
40 
41 
42 
43 
44 
45 
Recovery 
1 
3 
5 
10 
8.5 
8.5 
8.5 
8.5 
9 
9 
9 
9 
9 
10 
10 
10 
11 
11 
11 
Force 
Matching % 
146 
97 
71 
58 
28 
31 
43 
43 
52 
58 
51 
46 
43 
58 
51 
46 
34 
43 
42 
59 
41 
52 
44 
43 
36 
31 
36 
45 
48 
45 
40 
42 
49 
42 
46 
38 
50 
57 
66 
67 
53 
48 
53 
51 
100 
66 
49 
40 
19 
21 
29 
29 
36 
40 
35 
32 
29 
40 
35 
32 
23 
29 
29 
40 
28 
36 
30 
29 
25 
21 
25 
31 
33 
31 
27 
29 
34 
29 
32 
26 
34 
39 
45 
46 
36 
33 
36 
35 
~ 
Reference !!; 
143 
100 
71.5 
43 
49 
42 
45 
42 
42 
44 
43 
44 
43 
44 
43 
42 
42 
45 
44 
44 
43 
46 
44 
44 
43 
42 
44 
43 
43 
43 
43 
42 
42 
41 
44 
41 
44 
42 
42 
44 
40 
41 
44 
41 
100 
70 
50 
30 
34 
29 
31 
29 
29 
31 
30 
31 
30 
31 
30 
29 
29 
31 
31 
31 
30 
32 
31 
31 
30 
29 
31 
30 
30 
30 
30 
29 
29 
29 
31 
29 
31 
29 
29 
31 
28 
29 
31 
29 
£.MQ. EMG 
Matching % Reference % 
0.065 
0.039 
0.032 
0.021 
0.018 
0 021 
0.02 
0.019 
0.022 
0.026 
0.024 
0.023 
0.022 
0.023 
0.023 
0.021 
0.022 
0.024 
0.021 
0.025 
0.024 
0.027 
0.021 
0.023 
0.025 
0.022 
0.023 
0.023 
0.022 
0.023 
0.025 
0.022 
0.027 
0.026 
0.031 
0.028 
0.023 
0.031 
0.028 
0.03 
0.031 
0.027 
0.027 
0.028 
100 
60 
49 
32 
28 
32 
31 
29 
34 
40 
37 
35 
34 
35 
35 
32 
34 
37 
32 
38 
37 
42 
32 
35 
38 
34 
35 
35 
34 
35 
38 
34 
42 
40 
48 
43 
40 
48 
43 
46 
48 
42 
42 
43 
0.067 
0.057 
0.036 
0.025 
0.025 
0.024 
0.026 
0.023 
0.025 
0.025 
0.025 
0.023 
0.023 
0.026 
0.025 
0.025 
0.022 
0.022 
0.023 
0.025 
0.023 
0.023 
0.024 
0.024 
0.022 
0.022 
0.026 
0.027 
0.028 
0.026 
0.025 
0.026 
0.03 
0.035 
0.036 
0.034 
0.035 
0.032 
0.033 
0.037 
0.025 
0.025 
0.026 
0.027 
100 
85 
54 
37 
37 
36 
39 
34 
37 
37 
37 
34 
34 
39 
37 
37 
33 
33 
34 
37 
34 
34 
36 
36 
33 
33 
39 
40 
42 
39 
37 
39 
45 
52 
54 
51 
52 
48 
49 
55 
37 
37 
39 
40 99 
Baseline 
MVC 
70% 
SO% 
30% 
Endurance 
1 
2 
3 
4 
• 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
11 
7 
5 
3 
3 
3 
3 
5 
5 
5 
5 
5 
5 
6 
6 
6 
7 
8 
8 
8 
8 
8 
9 
9 
9 
10 
10 
10 
10 
9 
9 
9 
9 
9 
10 
10 
10 
10 
36 10 
36 
37 
38 
39 
10 
10 
10 
11 
iO 11 
41 
42 
43 
44 
45 
Recovery 
1 
3 
• 
10 
11 
11 
11 
11 
11 
Force 
Matching ,% 
498 
287 
258 
170 
128 
144 
141 
222 
165 
186 
187 
166 
169 
150 
165 
192 
244 
227 
222 
182 
178 
197 
173 
195 
222 
192 
192 
210 
206 
248 
250 
231 
282 
206 
212 
226 
277 
267 
297 
261 
218 
263 
215 
169 
100 
56 
52 
34 
'" 29
26 
45 
37 
37 
36 
33 
34 
30 
33 
39 
49 
46 
45 
37 
36 
40 
35 
3~ 
45 
39 
39 
42 
41 
50 
50 
46 
57 
41 
43 
45 
56 
56 
60 
52 
44 
53 
43 
38 
Force 
Reference % 
461 
336 
240 
144 
144 
143 
143 
143 
144 
145 
145 
146 
145 
145 
146 
142 
145 
147 
147 
144 
144 
146 
144 
145 
146 
145 
145 
145 
143 
144 
145 
144 
146 
144 
143 
144 
142 
148 
147 
145 
145 
144 
144 
143 
100 
70 
50 
30 
30 
30 
30 
30 
30 
30 
30 
30 
30 
30 
30 
30 
30 
31 
31 
30 
30 
31 
30 
30 
30 
30 
30 
30 
30 
30 
30 
30 
30 
30 
30 
30 
30 
31 
31 
30 
30 
30 
30 
30 
EMG EMG 
Matching ~ Reference ~ 
0.38 100 
0.23 61 
0.14 37 
0.063 17 
0.045 
0.046 
0.055 
0.06 
0.056 
0.06 
0.068 
0.06 
0.066 
0.064 
0.067 
0.064 
0.06 
0.068 
0.056 
0.055 
0.058 
0.06 
0.059 
0.066 
0.069 
0.07 
0.071 
0.069 
0,075 
0.077 
0.069 
0.073 
0,11 
0.091 
0.094 
0.09 
0.1 
0.12 
0.12 
0.13 
0.088 
0.087 
0.073 
0.087 
12 
12 
14 
16 
15 
16 
18 
16 
17 
17 
18 
17 
16 
18 
15 
14 
15 
16 
16 
17 
18 
18 
19 
18 
20 
20 
18 
19 
29 
24 
25 
24 
26 
32 
32 
34 
23 
23 
19 
23 
0.32 
0.22 
0.12 
0.068 
0.05 
0.051 
0.05 
0.046 
0.045 
0.046 
0.046 
0.048 
0.05 
0.045 
0.046 
0.046 
0.046 
0.047 
0.045 
0.046 
0.048 
0.047 
0.042 
0.047 
0.049 
0.047 
0.048 
0.046 
0.049 
0.048 
0.046 
0.056 
0.052 
0.052 
0.059 
0.062 
0.061 
0.066 
0.075 
0.088 
0.09 
0.078 
0,072 
0.072 
100 
69 
38 
21 
16 
16 
16 
14 
14 
14 
14 
15 
16 
14 
14 
14 
14 
15 
14 
14 
15 
15 
13 
15 
15 
15 
15 
14 
15 
15 
14 
18 
16 
16 
18 
19 
19 
21 
23 
28 
26 
24 
23 
23 100 
Baseline 
MVC 11 
70% 8 
50% 6 
30% 4 
Endurance 
1 
2 
3 
4 
3 
3 
4 
4 
5 5 
6 
7 
8 
9 
5 
5 
4 
4 
10 5 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
28 
27 
28 
29 
5 
5 
5 
5 
5 
5 
5 
6 
6 
6 
6 
6 
6 
6 
7 
7 
7 
7 
7 
3D a 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
.. 
45 
Recovery 
1 
3 
5 
10 
a 
a 
a 
a 
9 
9 
9 
9 
10 
10 
10 
10 
10 
10 
10 
Force 
Matching ~ 
242 100 
166 69 
as 36 
53 22 
28 
29 
53 
37 
36 
41 
41 
58 
42 
46 
42 
73 
63 
58 
60 
62 
60 
55 
68 
70 
50 
52 
62 
56 
55 
60 
70 
67 
52 
61 
70 
73 
53 
as 
78 
73 
77 
57 
87 
82 
12 
12 
22 
15 
15 
17 
17 
24 
17 
19 
17 
30 
26 
24 
25 
26 
25 
23 
28 
29 
21 
21 
26 
23 
23 
25 
29 
28 
21 
25 
29 
30 
22 
36 
32 
30 
32 
24 
36 
34 
Force 
Reference !f 
237 100 
165 70 
118 50 
71 30 
73 
74 
73 
72 
71 
72 
74 
72 
74 
71 
71 
74 
70 
71 
73 
73 
70 
75 
72 
73 
73 
72 
73 
73 
74 
72 
71 
72 
73 
72 
73 
72 
73 
71 
72 
72 
72 
74 
72 
73 
31 
31 
31 
30 
30 
30 
31 
30 
31 
30 
30 
31 
30 
30 
31 
31 
30 
32 
30 
31 
31 
30 
31 
31 
31 
30 
30 
30 
31 
30 
31 
30 
31 
30 
30 
30 
30 
31 
30 
31 
Matching ~ Reference !!; 
0.142 100 007 100 
0.09 63 0.064 91 
0.06 42 0.056 80 
0.032 23 0.039 56 
0.025 
0.024 
0.031 
0.03 
18 
17 
22 
21 
0.031 22 
0.033 23 
0.033 23 
0.039 27 
0.037 26 
0.038 27 
0.038 27 
0.044 31 
0.04 28 
0.038 27 
0.038 27 
0.039 27 
0.038 27 
0.039 27 
0.039 27 
0.039 27 
0.038 27 
0.04 28 
0.044 31 
0.04 28 
0.032 23 
0.04 28 
0.044 31 
0.045 32 
0.044 31 
0.043 30 
0.042 30 
0.048 34 
0.041 29 
0.05 35 
0.047 33 
0.046 32 
0.05 
0.052 
0.04 
0.031 
35 
37 
28 
22 
0.034 
0.037 
0.037 
0.039 
0.037 
0.037 
0.037 
0.039 
0.039 
0.037 
0.038 
0.042 
0.039 
0.035 
0.037 
0.039 
0.03~ 
0.049 
0.039 
0.04 
0.04 
0.039 
0.04 
0.04 
0.039 
0.04 
0.042 
0.042 
0.045 
0.044 
0.045 
0.047 
0.044 
0.047 
0.045 
0.042 
0.05 
0.054 
0.054 
0.053 
49 
53 
53 
56 
53 
53 
53 
56 
56 
53 
54 
60 
56 
50 
53 
56 
54 
56 
56 
57 
57 
56 
57 
57 
56 
57 
60 
60 
64 
63 
64 
67 
63 
67 
64 
60 
71 
77 
77 
76 101 
Force 
RPE Matching % 
Baseline 
MVC 
70% 
50% 
30% 
Endurance 
2 
3 
4 
11 
8 
7 
5 
4 
4 
5 
5 
5 6 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
6 
6 
7 
7 
7 
7 
7 
7 
7 
7 
7 
7 
7 
8 
20 8 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
8 
8 
8 
8 
9 
8 
9 
9 
9 
10 
10 
10 
9 
9 
9 
9 
10 
10 
10 
11 
11 
11 
11 
11 
45 11 
Recovery 
1 8 
3 7 
5 8 
10 8 
36£ 
100 
117 
85 
138 
181 
83 
79 
73 
48 
43 
58 
74 
68 
92 
32 
42 
46 
77 
83 
97 
76 
78 
97 
75 
127 
6£ 
80 
78 
91 
67 
83 
85 
100 
90 
104 
114 
148 
133 
176 
100 
27 
32 
23 
38 
49 
23 
22 
20 
13 
12 
16 
20 
19 
25 
9 
11 
13 
21 
23 
27 
21 
21 
27 
20 
35 
15 
22 
21 
25 
18 
23 
23 
27 
25 
28 
31 
40 
36 
48 
123 34 
122 33 
Missed 
118 32 
Fore'! 
Refemnce 12 
348 
244 
174 
105 
106 
99 
102 
106 
101 
104 
104 
102 
98 
103 
106 
104 
110 
103 
97 
104 
101 
105 
104 
105 
101 
102 
106 
101 
103 
102 
106 
105 
110 
103 
101 
105 
102 
103 
104 
102 
103 
102 
105 
100 
70 
50 
30 
30 
28 
29 
30 
29 
30 
30 
29 
28 
30 
30 
30 
32 
30 
28 
30 
29 
30 
30 
30 
29 
29 
30 
29 
30 
29 
30 
30 
32 
30 
29 
30 
29 
30 
30 
29 
30 
29 
0 
30 
EMG EMG 
Matching :¥! Reference ~ 
0.090 
0.045 
0.050 
0.034 
0.037 
0.058 
0.048 
0.026 
0.026 
0.021 
0.018 
0.019 
0.013 
0.020 
0.021 
0.022 
0.028 
0.039 
Invalid 
0.024 
0.044 
0.020 
0.025 
0.022 
0.021 
0.025 
0.018 
0.032 
0.030 
0.032 
0.024 
0.032 
0.030 
0.033 
0.024 
Invalid 
Invalid 
100 
50 
56 
38 
41 
64 
53 
28 
28 
23 
20 
21 
14 
22 
23 
24 
31 
43 
27 
49 
22 
28 
25 
23 
28 
20 
35 
33 
36 
27 
35 
33 
36 
27 
0.188 
0.085 
0.049 
0.056 
0.028 
0.032 
0.017 
0.015 
0.030 
0.027 
0.023 
0.033 
Invalid 
0.026 
0.027 
0.034 
0.031 
0.026 
0.020 
0.032 
0.018 
0.035 
0.035 
0.025 
0.052 
0.038 
0.031 
Invalid 
Invalid 
100 
45 
26 
30 
15 
17 
9 
8 
16 
14 
0 
12 
18 
14 
14 
18 
16 
14 
11 
17 
10 
19 
19 
13 
27 
20 
16 
102 
Force 
RPE Matching % 
Baseline 
MVC 
70% 
SO% 
30% 
Endurance 
1 
2 
3 
4 
s 
• 
7 
8 
9 
11 
6 
4 
0.5 
0.5 
0.5 
1.5 
1.5 
10 1.5 
11 
12 
13 
1.5 
1.5 
2 
14 2 
15 2 
16 
17 
18 
19 
2 
2 
2 
2 
20 2.5 
21 
22 
23 
24 
2.5 
2.5 
2.5 
2.5 
25 3 
28 
27 
28 
29 
30 
31 
32 
33 
34 
3 
3 
3 
3 
3.5 
3.5 
3.5 
4 
4 
35 4 
38 
37 
38 
39 
.. 
41 
42 
43 
44 
4 
4.5 
4.5 
4.5 
5 
5 
5 
5 
5.5 
45 5.5 
Recovery 
1 
3 
s 
10 
410 
213 
205 
143 
112 
127 
114 
127 
152 
135 
117 
101 
117 
131 
125 
113 
128 
120 
117 
120 
112 
111 
106 
115 
126 
131 
129 
123 
126 
132 
128 
143 
130 
130 
123 
154 
144 
135 
133 
136 
134 
146 
116 
100 
52 
50 
35 
27 
31 
26 
31 
37 
33 
29 
25 
29 
32 
30 
28 
31 
29 
29 
29 
27 
27 
26 
28 
31 
32 
31 
30 
31 
32 
31 
35 
32 
32 
30 
38 
35 
33 
32 
33 
33 
36 
28 
~ 
Reference ~ 
378 
263 
188 
112 
110 
110 
110 
109 
111 
115 
109 
112 
112 
111 
112 
110 
112 
111 
113 
111 
112 
110 
110 
112 
110 
110 
110 
112 
111 
111 
110 
109 
110 
112 
111 
108 
110 
112 
111 
110 
111 
110 
111 
100 
70 
50 
30 
29 
29 
29 
29 
29 
30 
29 
30 
30 
29 
30 
29 
30 
29 
30 
29 
30 
29 
29 
30 
29 
29 
29 
30 
29 
29 
29 
29 
29 
30 
29 
29 
29 
30 
29 
29 
29 
29 
29 
EMG EMG 
Matching ~ Reference ~ 
0.19 100 
0.12 63 
0.1 53 
0.053 28 
0.066 
0.065 
0.06 
0.069 
0.067 
0.067 
0.069 
0.067 
0.064 
0.069 
0.072 
0.066 
0.075 
0.074 
0.076 
0.071 
0.075 
0.069 
0.074 
0,066 
0.074 
0.08 
0.065 
0.065 
0.066 
0.073 
0.078 
0.077 
0.085 
0.088 
0.082 
0.09 
0.084 
0.092 
0.094 
0.088 
0.071 
0.079 
0.088 
35 
34 
32 
36 
35 
35 
36 
35 
34 
36 
38 
35 
39 
39 
40 
37 
39 
36 
39 
35 
39 
42 
34 
34 
35 
38 
41 
41 
45 
46 
43 
47 
44 
48 
49 
46 
37 
42 
36 
0.24 
0.16 
0.12 
0.07 
0.039 
0.044 
0.042 
0 04 
0.042 
0.042 
0.04 
0.04 
0.04 
0.043 
0.039 
0.04 
0.043 
0.04 
0.039 
0.038 
0.04 
0.039 
0.039 
0.04 
0.04 
0.039 
0.039 
0.04 
0.039 
0.04 
0.046 
0.047 
0.047 
0.045 
0.046 
0.064 
0.05 
0.055 
0.051 
0.052 
0.055 
0.055 
0.04 
100 
67 
50 
29 
16 
18 
18 
17 
18 
18 
17 
17 
17 
18 
16 
17 
18 
17 
16 
16 
17 
16 
16 
17 
17 
16 
16 
17 
16 
17 
19 
20 
20 
19 
19 
27 
21 
23 
21 
22 
23 
23 
17 103 
Control1 
Baseline 
MVC 
70% 
50% 
30% 
Endurance 
1 
2 
3 
4 
5 
6 
7 
8 
9 
11 
5 
3 
05 
05 
1.5 
2 
2 
2 
10 2 
11 
12 
13 
,. 
2 
2 
3 
3 
15 3 
16 
17 
18 
19 
3 
3 
3 
3 
20 3.5 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
"" 44 
4 
4 
4 
4 
5 
5 
5 
5 
5 
5 
5.5 
6 
6 
6.5 
6.5 
7 
7 
7 
7.5 
7.5 
B 
B 
8 
8 
45 8.5 
Recovery 
1 
3 
• 
10 
Force 
Matching !! 
213 
75 
67 
42 
38 
34 
34 
38 
34 
41 
39 
32 
54 
41 
41 
38 
41 
46 
44 
57 
55 
53 
49 
51 
84 
55 
54 
55 
40 
59 
62 
.. 
76 
78 
.. 
69 
85 
90 
77 
94 
76 
73 
70 
58 
100 
35 
31 
20 
18 
16 
16 
18 
16 
19 
18 
15 
25 
19 
19 
18 
19 
22 
21 
27 
26 
25 
23 
24 
30 
26 
25 
26 
19 
28 
29 
31 
36 
37 
31 
32 
40 
42 
38 
44 
36 
34 
33 
27 
till.!! 
Reference ~ 
180 
126 
90 
54 
56 
56 
58 
55 
55 
53 
55 
54 
54 
55 
52 
54 
52 
54 
55 
55 
55 
54 
55 
56 
54 
55 
56 
54 
55 
52 
54 
53 
53 
56 
55 
56 
54 
53 
55 
55 
51 
53 
53 
55 
100 
70 
50 
30 
31 
32 
32 
31 
31 
29 
31 
30 
30 
31 
29 
30 
29 
30 
31 
31 
31 
30 
31 
31 
30 
31 
31 
30 
31 
29 
30 
29 
29 
31 
31 
31 
30 
29 
31 
31 
28 
29 
29 
31 
EMG EMG 
Matching :'A Reference !!! 
0 21 
O.Ofl 
o.ca 
0 04 
0.036 
0.028 
0.038 
0.029 
0.034 
0.035 
0.035 
0.038 
0.029 
0.03 
0.031 
0.032 
0.029 
0.035 
0.034 
0.042 
0.052 
0.042 
0.052 
0.05 
0.06 
0.06 
0.08 
0.067 
0.068 
0.06 
0.054 
0.051 
0.055 
0.075 
0.078 
0.087 
0.091 
0.098 
0.095 
0.099 
0.073 
0,05 
0.044 
0.035 
~00 
38 
33 
19 
17 
13 
18 
14 
16 
17 
17 
18 
14 
14 
15 
15 
14 
17 
16 
20 
25 
20 
25 
24 
29 
29 
38 
32 
32 
29 
26 
24 
26 
38 
37 
41 
43 
47 
45 
47 
35 
24 
21 
17 
0.23 
0 14 
0.07 
0.054 
0.068 
0.05 
0.066 
0.065 
0.05 
0.06 
0.052 
0.065 
0.066 
0.06 
0.06 
0.059 
0.063 
0.067 
0.065 
0.067 
0.073 
0.06 
0.06 
0.063 
0.055 
0.06 
0.06 
0.062 
0.062 
0.06 
0.061 
0.06 
0.0511 
0.069 
0.068 
0.067 
0.085 
0.071 
0.079 
0.079 
0.068 
0.06 
0.069 
0.065 
100 
01 
30 
23 
30 
26 
29 
28 
22 
26 
23 
28 
29 
26 
26 
25 
27 
29 
28 
29 
32 
26 
26 
27 
24 
26 
26 
27 
27 
26 
27 
26 
25 
30 
30 
29 
37 
31 
34 
34 
30 
26 
30 
28 104 
Control2 
Baseline 
MVC 
70% 
50% 
30% 
Endurance 
1 
2 
3 
4 
11 
7 
3 
1 
1 
• 1 
6 
1 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
2 
2 
2 
2 
2 
2 
2 
3 
3 
3 
4 
4 
4 
4 
4 
4 
5 
5 
5 
6 
6 
6 
7 
7 
30 7 
31 
32 
33 
34 
35 
38 
37 
38 
39 
40 
41 
42 
43 
44 
7 
8 
8 
8 
8 
9 
9 
9 
9 
9 
10 
10 
11 
11 
4lS 11 
Recovery 
1 
3 
s 
10 
Force 
Matching ~ 
250 
140 
128 
71 
49 
64 
52 
65 
63 
35 
66 
93 
59 
54 
67 
68 
50 
64 
72 
75 
88 
81 
80 
42 
53 
68 
70 
60 
70 
61 
74 
51 
98 
102 
87 
84 
92 
133 
89 
134 
96 
88 
59 
53 
100 
56 
51 
28 
20 
26 
21 
26 
25 
14 
26 
37 
24 
22 
27 
27 
20 
26 
29 
30 
35 
32 
32 
17 
21 
27 
28 
24 
28 
24 
30 
20 
39 
41 
35 
34 
37 
53 
38 
54 
38 
35 
24 
21 
Force 
Reference ~ 
271 
189 
135 
81 
82 
93 
85 
80 
82 
82 
81 
80 
83 
79 
75 
82 
77 
77 
81 
79 
91 
81 
80 
88 
82 
81 
81 
76 
78 
81 
74 
77 
76 
83 
83 
87 
80 
81 
79 
82 
88 
80 
82 
77 
100 
70 
50 
30 
30 
34 
31 
30 
30 
30 
30 
30 
31 
29 
28 
30 
28 
28 
30 
29 
34 
30 
30 
32 
30 
30 
30 
28 
29 
30 
27 
28 
28 
31 
31 
32 
30 
30 
29 
30 
32 
30 
30 
28 
Matching .%. Reference ~ 
0.27 100 
0.16 59 
0.071 26 
0.045 17 
0.038 
0.042 
0.032 
O.D28 
0.03 
0.032 
0.036 
0.036 
0.041 
0.05 
0.026 
0.05 
0.035 
0.028 
0.036 
0.041 
0.038 
0.04 
0.042 
0.034 
0.031 
0.035 
0.032 
0.027 
14 
16 
12 
10 
11 
12 
13 
13 
15 
19 
10 
19 
13 
10 
13 
15 
14 
15 
16 
13 
11 
13 
12 
10 
0.031 11 
0.027 10 
0.04 15 
0.034 13 
0.064 24 
0.053 20 
0.041 15 
0.066 24 
0.065 24 
0.1 37 
0.062 23 
0.11 41 
0.051 
0.032 
0.03 
0.03 
19 
12 
11 
11 
028 
0 19 
0.13 
0.068 
0.069 
0.07 
0.072 
0.07 
0.085 
0.066 
0.08 
0.075 
0.066 
0.077 
0.068 
0.062 
0.071 
0.061 
0.088 
0.084 
0.073 
0.06 
0.066 
0.07 
0.06 
0.065 
0.061 
0.067 
0.066 
0.084 
0.094 
0.068 
0.065 
0.08 
0.07 
0.097 
0.088 
0.088 
0.12 
0.1 
0.093 
0.09 
0.075 
0.092 
100 
68 
46 
24 
25 
25 
26 
25 
30 
24 
29 
27 
24 
28 
24 
22 
25 
22 
31 
30 
26 
21 
24 
25 
21 
23 
22 
24 
24 
30 
34 
24 
23 
29 
25 
35 
31 
31 
43 
36 
33 
32 
27 
33 105 
Control 3 
Force 
RPE Matching %: 
Baseline 
MVC 11 
70% 6 
50% 3 
30% 
Endurance 
1 
2 
3 1.5 
• 2 
5 2 
6 2 
7 2 
8 2 
9 2 
10 3 
11 
12 
13 
14 
3 
3 
3 
3 
15 3.5 
16 3.5 
17 
18 
19 
20 
21 
22 
23 
24 
25 
28 
27 
28 
29 
4 
4 
4 
4.5 
5 
5 
5 
5 
5.5 
5.5 
6 
6 
6 
30 6.5 
31 
32 
33 
34 
35 
36 
37 
38 
39 
6.5 
6.5 
7 
7 
7 
7 
7 
7 
7 
40 7 
41 
42 
43 
44 
7 
7.5 
7.5 
6 
45 8 
Recovery 
1 
3 
5 
10 
367 
144 
132 
91 
56 
70 
61 
66 
87 
78 
66 
73 
85 
82 
70 
84 
82 
76 
84 
74 
72 
80 
85 
70 
74 
81 
74 
70 
90 
99 
91 
89 
92 
86 
70 
90 
105 
87 
98 
118 
188 
110 
129 
100 
39 
36 
25 
15 
19 
17 
18 
24 
21 
18 
20 
23 
22 
19 
23 
22 
21 
23 
20 
20 
22 
23 
19 
20 
22 
20 
19 
25 
27 
25 
24 
25 
23 
19 
25 
29 
24 
27 
32 
45 
30 
35 
Force 
Reference ~ 
324 
228 
163 
97 
96 
98 
97 
96 
99 
98 
98 
97 
97 
98 
96 
97 
97 
95 
98 
96 
97 
95 
96 
96 
97 
95 
96 
96 
97 
96 
97 
97 
98 
98 
97 
98 
97 
96 
95 
93 
93 
96 
96 
100 
70 
50 
30 
30 
30 
30 
30 
31 
30 
30 
30 
30 
30 
30 
30 
30 
29 
30 
30 
30 
29 
30 
30 
30 
29 
30 
30 
30 
30 
30 
30 
30 
30 
30 
30 
30 
30 
29 
29 
29 
30 
30 
EMG EMG 
Matching %: Reference ~& 
0.34 
0.167 
014 
0 09 
0.046 
0.05 
0.048 
0.05 
0.055 
0.056 
0.049 
0.05 
0.052 
0.049 
0.047 
0.047 
0.05 
0.05 
0.048 
0.048 
0.046 
0.048 
0.05 
0.048 
0.047 
0.046 
0.048 
0.049 
0.05 
0.057 
0.049 
0.047 
0.049 
0.049 
0.046 
0.051 
0.051 
0.049 
0,053 
0.061 
0.082 
0.067 
0.082 
100 
49 
41 
26 
14 
15 
14 
15 
16 
16 
14 
15 
15 
14 
14 
14 
15 
15 
14 
14 
14 
14 
15 
14 
14 
14 
14 
14 
15 
17 
14 
14 
14 
14 
14 
15 
15 
14 
16 
16 
24 
20 
24 
0.31 
0.152 
0.09 
0.047 
0.035 
0.034 
0.036 
0.038 
0.035 
0.036 
0.035 
0.038 
0.039 
0.039 
0.037 
0.036 
0.037 
0.038 
0.043 
0.039 
0.045 
0.042 
0.046 
0.044 
0.039 
0.046 
0.04 
0.041 
0.049 
0.041 
0.049 
0.047 
0.051 
0,05 
0.041 
0.043 
0.054 
0.046 
0.048 
0.047 
0.044 
0.04 
0.048 
100 
49 
29 
15 
11 
11 
12 
12 
11 
12 
11 
12 
13 
13 
12 
12 
12 
12 
14 
13 
15 
14 
15 
14 
13 
15 
13 
13 
16 
13 
16 
15 
16 
16 
13 
14 
17 
15 
15 
15 
14 
13 
15 
106 
Control 4 
Force 
RPE Matching ~ 
Baseline 
MVC 
70% 
50% 
30% 
Endurance 
1 
2 
3 
4 
11 
3 
2 
1 
2 
2 
2 
5 2 
• 
7 
8 
9 
10 
11 
12 
13 
14 
3 
3 
3 
3 
3 
3 
3 
3 
3 
15 3 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
30 
39 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
4 
4 
4 
4 
4 
4 
4 
4 
40 4 
41 
42 
43 
44 
45 
Recovery 
1 
3 
5 
10 
4 
4 
5 
5 
5 
334 
178 
85 
79 
65 
61 
84 
80 
59 
62 
57 
52 
52 
48 
51 
53 
52 
60 
54 
82 
58 
59 
60 
55 
57 
58 
61 
65 
70 
87 
74 
70 
76 
92 
76 
70 
82 
89 
90 
102 
151 
154 
167 
143 
100 
53 
25 
24 
19 
18 
25 
24 
18 
19 
17 
16 
16 
14 
15 
16 
16 
18 
16 
25 
17 
18 
18 
16 
17 
17 
18 
19 
21 
26 
22 
21 
23 
28 
23 
21 
25 
27 
27 
31 
45 
46 
50 
43 
Force 
Reference ~ 
290 
203 
145 
87 
85 
87 
85 
86 
85 
84 
88 
87 
83 
87 
86 
88 
83 
87 
86 
88 
87 
87 
88 
88 
84 
82 
88 
86 
84 
82 
88 
86 
85 
86 
87 
86 
84 
82 
88 
87 
86 
85 
87 
88 
100 
70 
50 
30 
29 
30 
29 
30 
29 
29 
30 
30 
29 
30 
30 
30 
29 
30 
30 
30 
30 
30 
30 
30 
29 
28 
30 
30 
29 
28 
30 
30 
29 
30 
30 
30 
29 
28 
30 
30 
30 
29 
30 
30 
EMG EMG 
Matching ,% Reference % 
O.D78 100 
0.058 74 
0.05 64 
0.039 50 
0.029 
0.03 
0.024 
0.028 
0.027 
0.026 
0.027 
0.025 
0.029 
0.032 
O.D34 
0.034 
37 
3B 
31 
36 
35 
33 
35 
32 
37 
44 
44 
0.024 31 
0.025 32 
0.028 36 
0.03 38 
0.025 32 
0.026 33 
0.032 41 
0.03 38 
0.027 35 
0.029 37 
0.03 38 
0.033 42 
0.028 36 
0.026 33 
0.03 38 
0.029 37 
0.028 36 
0.029 37 
0.038 49 
0.036 46 
0.038 
0.045 
0.031 
0.038 
0.039 
0.033 
0.044 
0.048 
49 
58 
40 
49 
50 
42 
56 
62 
0.084 
0.071 
0.047 
0 026 
0.043 
0.036 
O.OJ7 
0.036 
0.039 
0.042 
0.036 
0.037 
0.039 
0.037 
0.037 
0.042 
0.037 
0.037 
0.038 
0.037 
0.039 
0.043 
0.039 
0.041 
0.041 
0.046 
0.038 
0.04 
0.038 
0.041 
0.042 
0.04 
0.041 
0.042 
0.056 
0.045 
0.041 
0.058 
0.042 
0.041 
0.039 
0.038 
0.045 
0.048 
100 
85 
56 
31 
51 
43 
44 
43 
46 
50 
43 
44 
46 
44 
44 
50 
44 
44 
45 
44 
46 
51 
46 
49 
49 
55 
45 
48 
45 
49 
50 
48 
49 
50 
67 
54 
49 
69 
50 
49 
46 
45 
54 
57 107 
ControlS 
Baseline 
MVC 11 
70% 5 
50% 3 
30% 
Endurance 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
2 
2 
2 
2 
3 
3 
3 
4 
4 
4 
4 
4 
5 
5 
5 
5 
5 
6 
6 
6 
6 
6 
6 
7 
7 
7 
7 
7 
7 
7 
7 
7 
3!5 8 
38 
37 
38 
39 
40 
41 
42 
43 
44 
45 
Recovery 
1 
3 
5 
10 
8 
8 
8 
8 
8 
8 
8 
8 
8 
8 
Force 
Matching !! 
334 tOO 
164 49 
112 34 
64 19 
67 
40 
76 
75 
76 
87 
78 
98 
96 
82 
82 
91 
103 
101 
83 
102 
75 
75 
81 
80 
96 
96 
81 
80 
94 
99 
106 
73 
46 
61 
97 
81 
88 
107 
93 
93 
102 
87 
105 
124 
20 
12 
23 
22 
23 
26 
23 
29 
29 
25 
25 
27 
31 
30 
25 
31 
22 
22 
24 
24 
29 
29 
24 
24 
28 
30 
32 
22 
14 
18 
29 
24 
28 
32 
28 
28 
31 
28 
31 
37 
EY.ffi! 
Reference !! 
306 100 
214 70 
153 50 
91 30 
91 
90 
89 
93 
90 
92 
90 
91 
92 
88 
91 
90 
95 
92 
91 
90 
92 
91 
90 
90 
91 
90 
89 
91 
93 
92 
91 
91 
09 
88 
90 
90 
89 
88 
91 
92 
91 
89 
90 
91 
30 
29 
29 
30 
29 
30 
29 
30 
30 
29 
30 
29 
31 
30 
30 
29 
30 
30 
29 
29 
30 
29 
29 
30 
30 
30 
30 
30 
29 
29 
29 
29 
29 
29 
30 
30 
30 
29 
29 
30 
Matching !! Reference ~ 
0.2 100 0.19 100 
0.19 95 0.11 58 
0.045 23 0.07 37 
0.023 12 0 04 21 
0.02 
0.022 
0.019 
0.021 
0.02 
0.019 
0.019 
0.023 
0.02 
0.019 
0.022 
0.021 
0.02 
0.021 
0.024 
0.02 
0.023 
0.024 
0.021 
0.019 
0.023 
0.022 
0.024 
0.025 
0.022 
0.023 
0.029 
0.023 
0.021 
0.024 
0.031 
0.045 
0.03 
0.031 
0.042 
0,03 
0.019 
0.015 
0.021 
0.019 
10 
11 
10 
11 
10 
10 
10 
12 
10 
10 
11 
11 
10 
11 
12 
10 
12 
12 
11 
10 
12 
11 
12 
13 
11 
12 
15 
12 
11 
12 
16 
23 
15 
16 
21 
15 
10 
8 
11 
10 
0.044 
0.047 
0.042 
0.05 
0.045 
0.047 
0.049 
0.055 
0.055 
0.058 
0.055 
0.058 
0.057 
0.056 
0.052 
0.058 
0.058 
0.062 
0.065 
0.0£ 
0.05 
0.053 
0.0£ 
0.057 
0.065 
0.063 
0.065 
0.059 
0.06 
0.067 
0.059 
0.065 
0.062 
0.067 
0.063 
0.062 
0.051 
0.056 
0.065 
0.067 
23 
25 
22 
26 
24 
25 
26 
29 
29 
31 
29 
31 
30 
29 
27 
31 
31 
33 
34 
32 
26 
28 
32 
30 
34 
33 
34 
31 
32 
35 
31 
34 
33 
35 
33 
33 
27 
29 
34 
35 108 
Control 6 
Baseline 
MVC 11 
70% 5 
50"/o 2 
30% 05 
Endurance 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
18 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
'" 36
37 
38 
39 
..., 
41 
42 
43 
44 
45 
Recovery 
1 
3 
5 
10 
0.5 
0.5 
1 
1 
2 
2 
2 
3 
3 
3 
3 
3.5 
3.5 
4 
4 
4 
4 
5 
5 
5 
5 
5 
5 
5.5 
6 
6 
6 
6 
6 
6 
6.5 
6.5 
6.5 
7 
7 
7 
7 
7 
7 
7 
6 
6 
8 
8 
8 
Force 
Matching ~ 
383 
144 
149 
64 
56 
54 
52 
67 
81 
69 
82 
57 
64 
60 
61 
52 
48 
58 
59 
58 
59 
71 
58 
63 
58 
54 
54 
58 
42 
55 
55 
81 
81 
65 
69 
53 
49 
64 
64 
45 
64 
63 
59 
100 
38 
39 
17 
15 
14 
14 
17 
21 
18 
21 
15 
17 
16 
0 
16 
14 
13 
15 
15 
15 
15 
19 
15 
16 
15 
14 
14 
15 
11 
14 
14 
21 
16 
17 
18 
14 
13 
17 
17 
12 
H 
16 
15 
Force 
Reference %: 
362 
253 
181 
108 
106 
105 
105 
106 
108 
106 
103 
108 
108 
106 
106 
108 
105 
103 
105 
105 
106 
108 
108 
106 
103 
107 
104 
107 
108 
106 
107 
107 
108 
108 
107 
106 
104 
104 
105 
105 
106 
106 
107 
100 
70 
50 
30 
29 
29 
29 
29 
30 
29 
28 
30 
30 
29 
0 
29 
30 
20 
28 
29 
29 
29 
30 
30 
29 
28 
29 
29 
29 
30 
29 
29 
29 
30 
30 
29 
29 
29 
29 
29 
29 
29 
29 
29 
EMG EMG 
Matching ~ Reference !! 
03 
0.24 
0.13 
0 047 
100 
80 
43 
16 
0.026 9 
0.022 7 
0.028 9 
0.029 10 
0.031 10 
0.032 11 
0.048 16 
0.029 10 
0.03 10 
0.036 12 
0 
0.032 11 
0.033 11 
0.035 12 
0.031 10 
0.031 10 
0.029 10 
0.031 10 
0.034 11 
0.034 11 
0.038 13 
0.038 13 
0.032 11 
0.03 10 
0.036 12 
0.03 10 
0.034 11 
0.038 13 
0.044 15 
0.038 13 
0.044 15 
0.05 17 
0.058 19 
0.068 . 23 
0,058 19 
0.063 21 
Invalid 
0.3 
03 
0 1 
0 07 
0 055 
0 059 
0.056 
0.057 
0.058 
0.055 
0.057 
0.054 
0.053 
0.054 
0.056 
0.052 
0.05 
0.051 
0.051 
0.05 
0.05 
0.055 
0.052 
0.054 
0.052 
0.055 
0.06 
0.052 
0.053 
0.053 
0.054 
0.057 
0.062 
0.07 
O.D75 
0.068 
0.072 
0.07 
0.069 
0.07 
0.068 
0.068 
0.065 
100 
100 
33 
23 
18 
20 
19 
19 
19 
18 
19 
18 
18 
18 
0 
19 
17 
17 
17 
17 
17 
17 
18 
17 
18 
17 
18 
20 
17 
18 
18 
18 
19 
21 
23 
25 
23 
24 
23 
23 
23 
23 
23 
22 109 
Buel!na Menuromenta 
Force (newtons) 
MY(; 
Subje<:t 1 
Subject2 
Subject3 
Subject 4 
Subjects 
Subject 6 
Mean 
StDev 
SEM 
IMAm:! 
~§ 
234 
143 
~ 
100 
271 
461 324 
237 2fl0 
348 30.) 
378 362 
303.5 288.83 
121.70 61.72 
49.69 25.20 
MPiching Arm 
Cf..§ CQn!!Q! 
262 213 
146 250 
498 367 
242 334 
366 334 
410 383 
320.67 313.50 
127.77 67 33 
52.17 27.49 
Matching Force (Normalised) 
Subject! 
Subject 2 
Subjecl3 
Subject4 
SubjectS 
SubjectS 
70% Match 
CFS Control 
35 35 
66 56 
58 39 
69 53 
27 49 
52 38 
50% Match 
CFS control 
29 31 
49 51 
52 36 
36 25 
32 34 
50 39 
30% Match 
CFS Control 
16 20 
40 28 
34 25 
22 24 
23 19 
35 17 
Mean 51.17 45.00 41.33 36.00 28.33 22.17 
St Dev 16.92 8.79 10.15 8.76 9.31 4.17 
SEM 6.91 3.59 4.15 3.58 3.80 1.70 
Matching EMG (Normalised) 
70% Match 50% Match 30% Match 
CFS Control CFS ~ CFS .Q2ntr.Q! 
Subject1 35 38 25 33 25 19 
Subject2 
Subject 3 
Subject4 
Subject 5 
SubjectS 
Mean 
StOev 
SEM 
Subject 1 
Subject2 
Subject 3 
Subject4 
Subject 5 
Subject 6 
Mean 
Sldev 
SEM 
60 
61 
63 
50 
63 
59 
49 
74 
95 
80 
49 
37 
42 
56 
53 
26 
41 
64 
23 
43 
55.33 
10.11 
4.13 
65.83 43.67 38.33 
13.56 
5.54 
19.25 10.51 
7.86 4.29 
= :mli lli ~ ~ .QQo1rQ! 
11 11 8 5 
11 11 8 7 
11 11 7 6 
11 11 8 3 
11 11 8 5 
11 11 6 5 
11.00 11.00 7.50 6.17 
0.00 0.00 0.64 1.33 
0 0.00 0.34 0.54 
32 
17 
23 
38 
28 
17 
26 
50 
12 
16 
27.17 23.33 
8.67 12.64 
2.72 5.16 
§.llll 
lli 
7 
6 
5 
6 
7 
4 
5.83 
1.17 
0.'18 
Control 
3 
3 
3 
2 
3 
2 
2.87 
0.52 
0.21 
EMG {Volta) 
MY(; 
Subject 1 
Subjccl2 
Bel Arm 
ru 
0 191 
0 067 
.c.2!l!!2! 
023 
028 
SubjCCI 3 0 32 0.31 
Subject 4 0 07 0.084 
Subject 5 0 188 0 19 
Subject 6 0.24 0.3 
Mean 0.18 0.23 
St Dev 0.10 0.09 
SEM 0.04 0.03 
30% 
lli 
3 
3 
3 
4 
5 
1 
3.17 
1.33 
0.54 
~ 
1 
1 
1 
1 
1 
0.5 
0.92 
0.20 
0.08 
Mil.l!:bmg.AmJ 
C.E.S Qnntrol 
0.2 0 21 
0 065 0 'l7 
0.38 0 34 
0.142 0 078 
0.09 0 2 
0.19 0 J 
0.18 0.23 
0.11 0.09 
0.05 0.04 
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Appendix 
MVC force & EMG for Fatiguing Task 
Endurance MVC- Force for Fatiguing Task (Normalised) 
CFS 
Subject 1 Subject 2 Subject ~ §ub!ect 4 §ubject 5 Subject 6 Mean St. Dey SEM_ 
Endurance 
MVC 100 100 100 100 100 100 100 0 0 
5 90 92 61 62 92 93 66 5 2 
10 94 66 69 76 79 95 67 7 3 
15 92 92 77 61 64 95 67 7 3 
20 94 64 64 70 62 90 64 6 3 
25 65 76 76 57 64 61 77 10 4 
30 65 80 63 62 78 90 80 9 4 
35 61 77 70 70 68 88 72 9 4 
40 65 62 58 76 55 83 67 11 4 
45 86 53 46 76 53 64 86 18 7 
Recovery 
1 77 68 71 74 62 84 73 7 3 
3 77 97 63 73 69 96 82 12 5 
5 71 103 93 103 99 94 14 6 
10 100 108 90 91 74 104 95 12 5 
Endurance MVC -Force for Fatiguing Task !Normalised) 
Controls 
SubJect 1 Sublect 2 Subject 3 Sublecl 4 SubJect 5 Subject 6 Mean StDev SEM 
Endurance 
MVC 100 100 100 100 100 100 100 0 0 
5 88 85 92 87 a1 69 87 4 1 
10 67 79 93 99 65 80 62 10 4 
15 81 82 87 68 81 75 79 10 4 
20 74 74 86 81 44 86 74 16 6 
25 71 69 81 84 80 75 77 6 2 
30 66 68 67 76 63 69 72 9 4 
35 66 65 86 71 63 73 72 9 4 
40 58 58 66 69 80 56 65 11 5 
45 66 52 71 66 64 53 62 6 3 
Recovery 
1 75 62 72 74 71 64 73 7 3 
3 76 67 65 77 72 85 74 6 3 
5 85 65 81 80 80 89 80 6 3 
10 83 74 78 87 85 97 84 8 3 
Ill 
Appendix 
MVC rmsEMG for Fatiguing Task !Normalised} 
CFS 
SubJect 1 Sub1ect 2 Subjec+D' Subjcct4 Subject 5 Sybjecl6 Mean St De!l SEM 
Endurance 
MVC 100 100 100 100 100 100 100 0 
5 105 54 66 71 79 75 19 • 
10 68 48 59 77 75 65 12 5 
15 68 51 41 70 83 83 17 7 
20 58 46 50 66 79 60 13 6 
25 53 48 53 76 71 60 12 6 
30 53 48 47 61 75 57 12 5 
35 37 51 47 81 75 58 19 8 
40 47 54 41 76 67 57 14 6 
45 63 66 38 76 71 63 15 7 
Recovery 
1 32 48 53 74 71 56 17 8 
3 42 63 69 66 67 61 11 5 
5 32 69 75 79 79 67 20 9 
10 53 72 69 84 71 70 11 5 
MVC nnsEMG for Fatiguing Task !Normalised) 
Controls 
Subject 1 Subiect 2 Subiect 3 Subject 4 Subject 5 Subject 6 Mean St. Dev SEM 
Endurance 
uvc 100 100 100 100 100 100 100 0 
5 65 93 97 143 89 63 92 29 13 
10 61 61 65 119 58 40 67 27 12 
15 61 50 74 113 68 50 69 23 10 
20 48 50 74 107 42 43 61 26 11 
25 57 46 58 131 53 37 64 34 15 
30 57 39 58 94 47 47 57 19 9 
35 57 36 61 101 53 43 59 23 10 
40 48 36 71 151 63 37 68 43 19 
.. 57 46 68 145 79 30 71 40 18 
Recovery 
1 57 54 39 79 63 43 56 14 6 
3 48 64 48 81 79 43 61 17 7 
5 70 64 68 111 89 57 77 20 9 
10 61 71 84 104 95 60 79 16 8 
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BfS 
Control Subjec;!_1 Subject 2 §~t!iC!<;:l~ §_1.!!1iC!<;:L 4 $utuect.? §):!l;lject § M.@.an S! DQ_\1 ~~M 
Endurance 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
0.5 
0.5 
1 
1 
1 
).5 
2 
2 
2 
2 
2 
2 
3 
3 
3 
3 
3 
3 
3 
3.5 
4 
4 
4 
4 
5 
5 
5 
5 
5 
5 
5.5 
6 
6 
6.5 
6.5 
7 
7 
7 
7.5 
7.5 
8 
8 
8 
a 
8.5 
1 
1 
2 
2 
2 
2 
2 
2 
2 
3 
3 
3 
4 
4 
4 
4 
4 
4 
5 
5 
5 
6 
6 
6 
7 
7 
7 
7 
8 
8 
8 
8 
9 
9 
9 
9 
9 
10 
10 
11 
11 
11 
1 
15 
2 
2 
2 
2 
2 
2 
3 
3 
3 
3 
3 
3.5 
3.5 
4 
4 
4 
4.5 
5 
5 
5 
5 
5.5 
5.5 
6 
6 
6 
6.5 
6.5 
6.5 
7 
7 
7 
7 
7 
7 
7 
7 
7 
7.5 
7.5 
8 
8 
1 
1 
2 
2 
2 
2 
3 
3 
3 
4 
4 
4 
4 
4 
5 
5 
5 
5 
5 
6 
6 
6 
6 
6 
6 
7 
7 
7 
7 
7 
7 
7 
7 
7 
8 
8 
B 
8 
8 
8 
8 
8 
8 
8 
8 
1 
2 
2 
2 
2 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
4 
4 
4 
4 
4 
4 
4 
4 
4 
4 
4 
5 
5 
5 
0.5 
0.5 
2 
2 
2 
3 
3 
3 
3 
35 
3.5 
4 
4 
4 
4 
5 
5 
5 
5 
5 
5 
5.5 
6 
6 
6 
6 
6 
6 
6.5 
6.5 
6.5 
7 
7 
7 
7 
7 
7 
7 
8 
8 
8 
8 
8 
0.83 026 011 
1.00 0 55 0 22 
142 049 020 
1.50 0.55 022 
1.67 0 52 021 
2.08 0 49 0 20 
2.33 0.52 0 21 
2.50 0.55 0.22 
2.50 0.55 0.22 
2.83 0.75 0.31 
2.83 0 75 0.31 
2.92 0.80 0.33 
3.25 042 0_17 
3.33 0.52 0.21 
3.58 0.80 0.33 
3.75 0.76 0.31 
3.83 0.75 0.31 
4.00 0.89 0.37 
4.00 0.89 0.37 
4.33 1.08 0.44 
4.50 105 0.43 
4.67 1.03 0.42 
4.67 1.03 0.42 
4.75 1.08 0.44 
5.25 1.17 0.48 
5.42 1.36 0.55 
5.50 1.38 0.56 
5.67 1.51 0.61 
5.67 1.51 0.61 
5.75 1.54 0.63 
5.92 1.53 0.62 
6,33 1.33 0.54 
6.42 1.36 0.55 
6.58 1.36 0.55 
6.75 1.47 0.60 
7.00 1.67 0.68 
7.00 1.67 0.68 
7.00 1.67 0.68 
7.08 1.69 0.69 
7.08 1.69 0.69 
7.50 1.97 0.81 
7.58 1.96 0.80 
7.92 1.91 0.78 
8.00 1.90 0.77 
8.08 1.91 0.78 
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BfE 
CFS Subject 1 Subject 2 SubjEj;cl 3 §J!!:!jccl__1: Sub!Q_c;!_§ .$J!Q.iect 6 Meal} ST Q~_y SEM 
Endurance 
1 3 
2 3 
3 4 
4 4 
5 4 
6 4 
7 5 
8 5 
9 5 
10 6 
11 G 
12 7 
13 6 
14 6 
15 7 
16 7 
17 7 
18 7 
19 7 
20 8 
21 8 
22 8 
23 8 
24 8 
25 8 
26 8 
27 8 
28 8 
29 8.5 
30 8.5 
31 8.5 
32 6.5 
33 6,5 
34 8,5 
35 9 
36 9 
37 9 
38 9 
39 9 
40 10 
41 10 
42 10 
43 11 
44 11 
45 11 
2 
2 
2 
2 
3 
3 
3 
3 
3 
3 
3 
4 
4 
4 
4 
4 
5 
5 
5 
5 
8 
8 
6 
7 
7 
7 
7 
8 
6 
6 
8 
8 
8 
8 
9 
9 
9 
9 
10 
10 
10 
10 
10 
10 
10 
3 
3 
3 
5 
5 
5 
5 
5 
5 
6 
6 
6 
7 
8 
8 
8 
8 
8 
9 
9 
9 
10 
10 
10 
10 
9 
9 
9 
9 
9 
10 
10 
10 
10 
10 
10 
10 
10 
11 
11 
11 
11 
11 
11 
11 
4 
4 
5 
5 
6 
6 
6 
7 
7 
7 
7 
7 
7 
7 
7 
7 
7 
7 
6 
6 
6 
8 
6 
8 
9 
8 
9 
9 
9 
10 
10 
10 
9 
9 
9 
9 
10 
10 
10 
11 
11 
11 
11 
11 
11 
3 
3 
4 
4 
5 
5 
5 
4 
4 
5 
5 
5 
5 
5 
5 
5 
5 
6 
6 
6 
6 
6 
6 
6 
7 
7 
7 
7 
7 
8 
8 
8 
8 
8 
9 
9 
9 
9 
10 
10 
10 
10 
10 
10 
10 
0.5 
0.5 
0.5 
1 
1.5 
'.5 
1.5 
1.5 
1.5 
2 
2 
2 
2 
2 
2 
2 
2.5 
2.5 
2.5 
2.5 
2.5 
3 
3 
3 
3 
3 
3.5 
3.5 
3.5 
4 
4 
4 
4 
4.5 
4.5 
4.5 
5 
5 
5 
5 
5.5 
5.5 
2.58 1.20 0.49 
2.58 1.20 0.49 
3.08 1.63 0.66 
3.50 1.64 0,67 
4.00 1.79 0.73 
4.00 1.79 0.73 
4.17 1.83 0.75 
4.25 1.89 0.77 
4.25 1.89 0.77 
4.75 2.09 0.85 
4.75 2.09 0.85 
5.08 2.11 0,86 
5.17 1.94 0.79 
5.33 2.16 0.88 
5.50 2.26 0.92 
5.50 2.26 0.92 
5,67 2.16 0.88 
5.83 2.14 0.87 
6.17 2.48 1.01 
6.42 2.42 0.99 
6.58 2.33 0.95 
6.75 2.56 1.05 
6.75 2.56 1.05 
6.92 2.54 1.04 
7.33 2.42 0.99 
7.00 2.10 0.86 
7.17 2.23 0.91 
7.33 2.25 0.92 
7.42 2.29 0.93 
7.83 2.25 0.92 
8.00 2.39 0.97 
8.00 2.39 0.97 
7.92 2.06 0.84 
7.92 2.06 0.84 
8.33 2.16 0.88 
8.33 2.16 0.88 
8.58 2.06 0.84 
8.58 2.06 0,84 
9.08 2.33 0.95 
9.50 2.26 0.92 
9.50 2.26 0.92 
9.50 2.26 0.92 
9.67 2.34 0.95 
9.75 2.14 0,87 
9.75 2.14 0.87 
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I 
Control 
Reference EMG - Nonnalised 
Subject 1 Subject 2 
Endurance 
1 30 25 
2 
3 
4 
Average 
6 
7 
8 
9 
Average 
11 
12 
13 
14 
Average 
16 
17 
18 
19 
Average 
21 
22 
23 
24 
Average 
26 
27 
28 
29 
Average 
31 
32 
33 
34 
Average 
36 
37 
38 
39 
Average 
41 
42 
43 
44 
Average 
Recovery 
1 
3 
5 
10 
26 
29 
28 
28 
22 
26 
23 
28 
25 
29 
26 
26 
25 
27 
27 
29 
28 
29 
28 
32 
26 
26 
27 
28 
24 
26 
26 
27 
26 
27 
26 
27 
26 
26 
25 
30 
30 
29 
28 
37 
31 
34 
34 
34 
30 
28 
30 
28 
25 
26 
25 
25 
30 
24 
29 
27 
27 
24 
28 
24 
22 
24 
25 
22 
31 
30 
27 
26 
21 
24 
25 
24 
21 
23 
22 
24 
23 
24 
30 
34 
24 
28 
23 
29 
25 
35 
28 
31 
31 
43 
36 
35 
33 
32 
27 
33 
SubJect 3 Subloct 4 Subject !5 Subject 6 
11 
11 
12 
12 
12 
11 
12 
11 
12 
12 
13 
13 
12 
12 
12 
12 
12 
14 
13 
13 
15 
14 
15 
14 
14 
13 
15 
13 
14 
13 
16 
13 
16 
15 
15 
16 
16 
13 
15 
14 
17 
15 
15 
16 
15 
14 
13 
15 
51 
43 
44 
43 
45 
46 
50 
43 
44 
46 
46 
44 
44 
50 
46 
44 
44 
45 
44 
44 
46 
51 
46 
49 
46 
49 
55 
45 
48 
49 
45 
49 
50 
48 
48 
49 
50 
67 
54 
55 
49 
69 
50 
49 
54 
46 
45 
54 
57 
23 
25 
22 
26 
24 
24 
25 
26 
29 
26 
29 
31 
29 
31 
30 
30 
29 
27 
31 
29 
31 
33 
34 
32 
32 
26 
28 
32 
30 
29 
34 
33 
34 
31 
33 
32 
35 
31 
34 
33 
33 
35 
33 
33 
33 
27 
29 
34 
35 
18 
20 
19 
19 
19 
19 
18 
19 
18 
19 
18 
18 
19 
18 
17 
17 
17 
17 
17 
17 
17 
18 
17 
17 
.18· 
17 
18 
20 
18 
17 
18 
18 
18 
18 
19 
21 
23 
25 
22 
23 
24 
23 
23 
23 
23 
23 
23 
22 
26 
25 
25 
26 
26 
25 
26 
25 
26 
14 
10 
11 
10 
11 
12 
13 
11 
11 
26 11 
26 12 
26 11 
27 12 
26 13 
27 12 
29 10 
26 11 
27 12 
27 11 
27 11 
27 12 
27 14 
27 12 
27 12 
27 12 
25 12 
27 15 
26 11 
27 12 
26 12 
27 12 
29 12 
29 13 
27 11 
28 12 
27 12 
30 12 
32 18 
32 13 
30 13 
31 12 
35 18 
33 13 
32 11 
33 13 
29 10 
28 10 
30 14 
32 14 
6 
4 
4 
4 
5 
5 
5 
4 
4 
5 
5 
4 
5 
5 
5 
4 
5 
5 
4 
4 
5 
6 
5 
5 
5 
5 
6 
4 
5 
5 
5 
5 
5 
5 
5 
5 
5 
7 
5 
6 
5 
7 
5 
5 
5 
4 
4 
6 
6 
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!;!:§ 
Reference EMG Nonnalised 
Subject 1 SubJect 2 SubJect 3 SubJect 4 Subject 5 Subject 6 M!!n. St.dev SEM 
Endurance 
1 
2 
3 
4 
Average 
6 
7 
8 
9 
Average 
11 
12 
13 
14 
Average 
16 
17 
18 
19 
Average 
21 
22 
23 
24 
Average 
26 
27 
28 
29 
Average 
31 
32 
33 
34 
Average 
36 
37 
38 
39 
Average 
41 
42 
43 
44 
Average 
Recovery 
1 
3 
5 
10 
20 
25 
23 
17 
21 
17 
20 
17 
17 
18 
22 
23 
26 
22 
23 
17 
16 
20 
24 
19 
24 
20 
20 
21 
21 
20 
22 
26 
21 
22 
19 
21 
21 
20 
20 
23 
30 
20 
25 
25 
26 
31 
29 
35 
30 
17 
16 
18 
17 
37 
36 
39 
34 
37 
37 
37 
37 
34 
37 
34 
39 
37 
37 
37 
33 
33 
34 
37 
34 
34 
34 
36 
36 
35 
33 
33 
39 
40 
36 
42 
39 
37 
39 
39 
45 
52 
54 
51 
50 
52 
48 
49 
55 
51 
37 
37 
39 
40 
16 
16 
16 
14 
15 
14 
14 
14 
15 
14 
16 
14 
14 
14 
15 
14 
15 
14 
14 
14 
15 
15 
13 
15 
14 
15 
15 
15 
14 
15 
15 
15 
14 
16 
16 
16 
16 
18 
19 
18 
19 
21 
23 
28 
23 
28 
24 
23 
23 
49 
53 
53 
56 
53 
53 
53 
53 
56 
54 
56 
53 
54 
60 
56 
56 
50 
53 
56 
54 
54 
56 
56 
57 
56 
57 
56 
57 
57 
57 
56 
57 
60 
60 
56 
64 
63 
64 
67 
65 
63 
67 
64 
60 
64 
71 
77 
77 
76 
15 
17 
9 
6 
12 
16 
14 
12 
14 
16 
18 
14 
14 
14 
18 
16 
16 
14 
11 
17 
14 
10 
19 
19 
16 
13 
27 
20 
16 
19 
16 25 
18 28 
18 26 
17 24 
17 26 
18 26 
18 26 
17 28 
17 25 
17 26 
17 27 
18 29 
16 30 
33 
17 30 
17 27 
18 24 
17 28 
16 27 
17 27 
16 27 
17 28 
16 28 
16 27 
16 28 
17 26 
17 25 
16 31 
16 28 
16 27 
17 30 
16 26 
17 28 
19 29 
17 28 
20 30 
20 35 
19 33 
19 33 
19 33 
27 37 
21 37 
23 38 
21 40 
23 38 
39 
39 
39 
39 
14 
14 
16 
16 
16 
16 
16 
17 
17 
18 
16 
16 
17 
20 
16 
18 
14 
16 
17 
16 
15 
17 
18 
17 
18 
17 
17 
18 
17 
17 
18 
18 
18 
17 
17 
20 
19 
21 
21 
20 
19 
20 
18 
17 
18 
23 
27 
27 
27 
6 
6 
7 
7 
6 
6 
6 
7 
7 
7 
6 
7 
7 
8 
7 
7 
6 
7 
7 
6 
6 
7 
7 
7 
7 
7 
7 
7 
7 
7 
7 
7 
7 
7 
7 
8 
8 
8 
9 
8 
8 
8 
7 
7 
8 
10 
11 
11 
11 
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Control 
Matching EMG- Normalised 
Subject 1 Subject 2 Sublect 3 Subjecl4 Subject 5 SubjectS Mean St.dev SEM 
Endurance 
1 
2 
3 
4 
Average 
6 
7 
8 
9 
Average 
11 
12 
13 
14 
Average 
16 
17 
18 
19 
Average 
21 
22 
23 
24 
Average 
26 
27 
28 
29 
Average 
31 
32 
33 
34 
Average 
36 
37 
38 
39 
Average 
41 
42 
43 
44 
Average 
Recovery 
1 
3 
5 
10 
17 
13 
18 
14 
16 
16 
17 
17 
18 
17 
14 
14 
15 
15 
15 
14 
17 
16 
20 
17 
25 
20 
25 
24 
23 
29 
29 
38 
32 
32 
32 
29 
26 
24 
28 
26 
36 
37 
41 
35 
43 
47 
45 
47 
48 
35 
24 
21 
17 
14 
16 
12 
10 
13 
11 
12 
13 
13 
12 
15 
19 
10 
19 
15 
13 
10 
13 
15 
13 
14 
15 
16 
13 
14 
11 
13 
12 
10 
12 
11 
10 
15 
13 
12 
24 
20 
15 
24 
21 
24 
37 
23 
41 
31 
19 
12 
11 
11 
14 
15 
14 
15 
14 
16 
16 
14 
15 
15 
15 
14 
14 
14 
14 
15 
15 
14 
15 
14 
14 
14 
15 
14 
14 
14 
14 
14 
14 
14 
15 
17 
14 
15 
14 
14 
14 
14 
14 
15 
15 
14 
16 
15 
18 
24 
20 
24 
37 
38 
31 
36 
36 
35 
33 
35 
32 
34 
37 
41 
44 
44 
41 
31 
32 
36 
38 
34 
32 
33 
41 
38 
36 
35 
37 
38 
42 
38 
36 
33 
38 
37 
36 
36 
37 
49 
46 
42 
49 
58 
40 
49 
49 
50 
42 
58 
62 
10 
11 
10 
11 
10 
10 
10 
10 
12 
10 
10 
10 
11 
11 
10 
10 
11 
12 
10 
11 
12 
12 
11 
10 
11 
12 
11 
12 
13 
12 
11 
12 
15 
12 
12 
11 
12 
16 
23 
15 
15 
16 
21 
15 
17 
10 
8 
11 
10 
9 
7 
9 
10 
9 
10 
11 
16 
10 
12 
10 
12 
11 
11 
11 
12 
10 
10 
11 
10 
10 
11 
11 
11 
13 
13 
11 
10 
12 
12 
10 
11 
13 
12 
15 
13 
15 
17 
15 
19 
23 
19 
21 
21 
17 
17 
16 
16 
16 
16 
16 
17 
17 
17 
17 
18 
19 
19 
18 
16 
16 
17 
18 
17 
18 
17 
20 
18 
18 
19 
19 
21 
20 
20 
20 
18 
20 
19 
19 
21 
22 
24 
27 
24 
28 
32 
27 
31 
30 
26 
22 
24 
25 
10 4 
11 5 
8 3 
10 4 
10 4 
9 4 
9 4 
9 4 
8 3 
9 4 
10 4 
12 5 
14 6 
13 5 
12 5 
9 3 
8 3 
9 4 
11 4 
9 4 
9 4 
9 3 
12 5 
11 5 
10 4 
10 4 
11 4 
14 6 
14 6 
12 5 
11 5 
10 4 
10 4 
10 4 
10 4 
10 4 
12 5 
15 6 
13 5 
12 5 
15 6 
18 7 
12 5 
16 6 
15 6 
16 7 
14 6 
19 8 
21 9 
117 
CFS 
Matching EMG Normalised 
Subject 1 Subject 2 Subject 3 Subject 4 Subject 5 Subject 6 Mean St. Dev SEM 
Endurance 
1 
2 
3 
4 
Average 
6 
7 
8 
9 
Average 
11 
12 
13 
14 
Average 
16 
17 
18 
19 
Average 
21 
22 
23 
2.4 
Average 
26 
27 
28 
29 
Average 
31 
32 
33 
34 
Average 
36 
37 
38 
39 
Average 
41 
42 
43 
44 
Average 
Recovery 
1 
3 
5 
10 
12 
17 
12 
12 
13 
13 
17 
18 
15 
15 
15 
20 
18 
16 
17 
18 
20 
20 
18 
19 
17 
17 
17 
15 
16 
13 
14 
19 
17 
16 
26 
29 
18 
21 
23 
22 
18 
22 
21 
21 
19 
21 
20 
31 
23 
26 
15 
15 
n 
28 
32 
31 
29 
30 
34 
40 
37 
35 
37 
34 
35 
35 
32 
34 
34 
37 
32 
38 
35 
37 
42 
32 
35 
37 
38 
34 
35 
35 
36 
34 
35 
38 
34 
35 
42 
40 
48 
43 
43 
40 
48 
43 
46 
44 
48 
42 
42 
43 
12 
12 
14 
16 
14 
15 
16 
18 
16 
16 
17 
17 
18 
1? 
17 
16 
18 
15 
14 
16 
15 
16 
16 
17 
16 
18 
18 
19 
18 
18 
20 
20 
18 
19 
19 
29 
24 
25 
24 
25 
26 
32 
32 
34 
31 
23 
23 
19 
23 
18 
17 
22 
21 
19 
22 
23 
23 
27 
24 
26 
27 
27 
31 
28 
28 
27 
27 
27 
27 
27 
27 
27 
27 
27 
27 
28 
31 
28 
29 
23 
28 
31 
32 
28 
31 
30 
30 
34 
31 
29 
35 
33 
32 
32 
35 
37 
28 
22 
41 
64 
53 
28 
47 
28 
23 
20 
21 
23 
14 
22 
23 
24 
21 
31 
43 
37 
27 
49 
22 
28 
31 
25 
23 
28 
20 
24 
35 
33 
36 
27 
33 
35 
33 
36 
27 
33 
35 
34 
32 
36 
34 
35 
35 
36 
35 
36 
34 
36 
38 
36 
35 
39 
39 
40 
38 
37 
39 
36 
39 
38 
35 
39 
42 
34 
38 
34 
35 
38 
41 
37 
41 
45 
46 
43 
44 
47 
44 
48 
49 
47 
46 
37 
42 
36 
24 
29 
27 
24 
26 
24 
26 
25 
25 
25 
23 
26 
27 
24 
25 
27 
31 
27 
28 
28 
27 
32 
25 
27 
28 
26 
26 
29 
25 
27 
29 
30 
30 
29 
29 
33 
32 
34 
32 
33 
32 
36 
35 
39 
35 
36 
31 
29 
29 
12 
19 
15 
9 
13 
10 
10 
9 
9 
9 
9 
8 
9 
8 
8 
8 
11 
10 
12 
10 
10 
14 
8 
9 
10 
10 
9 
9 
8 
9 
7 
6 
10 
8 
7 
7 
10 
11 
10 
9 
11 
11 
11 
9 
10 
11 
11 
12 
10 
5 
8 
6 
4 
5 
4 
4 
4 
4 
4 
4 
3 
4 
3 
3 
3 
4 
4 
5 
4 
4 
6 
3 
4 
4 
4 
4 
4 
3 
4 
3 
2 
4 
3 
3 
3 
4 
4 
4 
4 
5 
4 
5 
3 
4 
5 
5 
6 
4 
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Control 
Matching Force ~ Normalised 
Endurance 
1 
2 
3 
4 
Average 
6 
7 
6 
9 
Average 
11 
12 
13 
14 
Average 
16 
17 
18 
19 
Average 
21 
22 
23 
24 
Average 
26 
27 
28 
29 
Average 
31 
32 
33 
34 
Average 
36 
37 
38 
39 
Average 
41 
42 
43 
44 
Average 
Recovery 
1 
3 
5 
10 
Subject 1 SubJect 2 Subject 3 Subject 4 Sub!ect 5 SubJect 6 Mean St.Dev §EM 
18 
16 
16 
18 
17 
16 
19 
18 
15 
17 
25 
19 
19 
18 
20 
19 
22 
21 
27 
22 
26 
25 
23 
24 
24 
30 
26 
25 
26 
27 
19 
28 
29 
31 
27 
36 
37 
31 
32 
34 
40 
42 
36 
44 
41 
36 
34 
33 
27 
20 
26 
21 
26 
23 
25 
14 
26 
37 
26 
24 
22 
27 
27 
25 
20 
26 
29 
30 
26 
35 
32 
32 
17 
29 
21 
27 
28 
24 
25 
28 
24 
30 
20 
26 
39 
41 
35 
34 
37 
37 
53 
36 
54 
4ll 
38 
35 
24 
21 
15 
19 
17 
18 
17 
24 
21 
18 
20 
21 
23 
22 
19 
23 
22 
22 
21 
23 
22 
20 
20 
22 
23 
21 
19 
20 
22 
20 
20 
19 
25 
27 
25 
24 
24 
25 
23 
19 
23 
25 
29 
24 
27 
26 
32 
45 
30 
35 
19 
18 
25 
24 
22 
18 
19 
17 
16 
17 
16 
14 
15 
16 
15 
16 
18 
16 
25 
19 
17 
18 
18 
16 
17 
17 
17 
18 
19 
18 
21 
26 
22 
21 
23 
23 
26 
23 
2'1 
24 
25 
27 
27 
31 
27 
45 
46 
50 
43 
20 
12 
23 
22 
19 
23 
26 
23 
29 
25 
29 
25 
25 
27 
26 
31 
30 
25 
31 
29 
22 
22 
24 
24 
23 
29 
29 
24 
24 
26 
26 
30 
32 
22 
26 
14 
16 
29 
24 
21 
26 
32 
26 
26 
29 
31 
26 
31 
37 
15 18 2.35 0.96 
14 17 4.76 1.94 
14 19 4.46 1.82 
17 21 3.67 1.50 
15 19 3.07 1.25 
21 21 3.59 1.47 
18 20 3.98 1.63 
21 21 3.64 1.49 
15 22 9.27 3.79 
19 21 3.87 1.58 
17 22 5.09 2.08 
16 20 3.97 1.62 
21 4.63 1.89 
16 21 5.35 2.18 
16 21 4.47 '.83 
14 20 6.69 2.73 
13 22 6.11 2.49 
15 21 5.17 2.11 
15 25 5.58 2.28 
14 22 5.30 2.17 
15 23 7.18 2,93 
15 22 6.08 2.48 
19 23 5.08 2.08 
15 20 4.18 1.71 
16 22 4,80 1.96 
16 22 5.91 2.41 
15 22 5.62 2.30 
14 22 5.07 2.07 
14 21 4.27 1.74 
15 22 4.90 2.00 
15 22 5.29 2.16 
11 24 6.63 2.71 
14 26 6.42 2.62 
14 22 5.48 2.24 
14 23 5.10 2.08 
21 26 9.53 3.89 
16 27 9.85 4.02 
17 ~6 6.47 2.64 
18 ,l5 6.77 2.76 
18 •:s 7.57 3.09 
14 28 9.44 3.86 
13 33 13.67 5,66 
17 26 7.36 3.01 
17 33 13.31 5.43 
15 30 10,80 4.41 
12 32 11.32 4.62 
17 34 11.26 4.61 
16 31 11.24 4,59 
15 30 10.39 4.24 
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.9.!:§ 
Matching Force Normalised 
Sub!ect 1 SubJect 2 SubJect 3 SubJect 4 SubJect !I SubJect 6 Mean St Dev SEM 
Endurance 
1 
2 
3 
4 
Average 
6 
7 
8 
9 
Average 
11 
12 
13 
14 
Average 
16 
17 
18 
19 
Average 
21 
22 
23 
24 
Average 
26 
27 
28 
29 
Average 
31 
32 
33 
34 
Average 
36 
37 
38 
39 
Average 
41 
42 
43 
44 
Average 
Recovery 
1 
3 
• 
10 
11 
13 
13 
15 
13 
20 
13 
9 
11 
13 
15 
14 
19 
19 
17 
20 
16 
24 
23 
21 
18 
19 
18 
13 
17 
19 
23 
27 
16 
21 
13 
20 
17 
18 
17 
18 
18 
18 
23 
19 
21 
21 
24 
25 
23 
14 
23 
25 
21 
19 
21 
29 
29 
25 
36 
40 
35 
32 
35 
29 
40 
35 
32 
34 
23 
29 
29 
40 
30 
28 
36 
30 
29 
31 
25 
21 
25 
31 
25 
33 
31 
27 
29 
30 
34 
29 
32 
26 
30 
34 
39 
45 
46 
41 
36 
33 
36 
35 
26 
29 
28 
45 
32 
37 
37 
38 
33 
36 
34 
30 
33 
39 
34 
49 
46 
45 
37 
44 
36 
40 
35 
39 
37 
45 
39 
39 
42 
41 
41 
50 
50 
46 
47 
57 
41 
43 
45 
46 
56 
58 
60 
52 
56 
44 
63 
43 
38 
12 
12 
22 
15 
15 
15 
17 
17 
24 
18 
17 
19 
17 
30 
2. 
26 
24 
25 
26 
25 
25 
23 
28 
29 
26 
21 
21 
26 
23 
23 
23 
25 
29 
28 
26 
21 
25 
29 
30 
26 
22 
36 
32 
30 
30 
32 
24 
36 
34 
38 
49 
23 
22 
33 
20 
13 
12 
16 
15 
20 
19 
25 
9 
18 
11 
13 
21 
23 
17 
27 
21 
21 
27 
24 
20 
35 
15 
22 
23 
21 
25 
18 
23 
22 
23 
27 
25 
28 
26 
31 
40 
36 
48 
39 
34 
33 
32 
32 
27 22 10.33 4.22 
31 26 13.87 5 66 
28 24 6.04 2.46 
31 26 11.23 4.59 
29 25 8.51 3.48 
37 27 10.25 4.19 
33 26 12.43 5.07 
29 23 12.16 4.97 
25 23 8.66 3.54 
31 2!1 10.49 4.28 
29 24 7.72 3.15 
32 26 9.85 4.02 
30 27 7.37 3.01 
26 11.78 4.81 
30 25 7.98 3.26 
28 26 12.55 5.12 
31 26 11.88 4.85 
29 29 8.39 3.42 
29 29 7.41 3.03 
29 28 9.44 3.86 
29 27 5.95 2.43 
27 27 8.45 3.45 
27 27 5.96 2.43 
26 27 8.56 3.50 
27 27 6.87 2.81 
28 26 9.51 3.88 
31 28 7.45 3.04 
32 27 7.77 3.17 
31 28 9.12 3.72 
31 27 7.40 3.02 
30 27 9.86 4.03 
31 30 10.48 4.28 
32 29 11.97 4.89 
31 29 9.71 3.96 
31 29 10.29 4.20 
35 31 14.21 5.80 
32 29 7.84 3.20 
32 30 8.22 3.36 
30 30 7.80 3.10 
32 30 9.24 3.77 
38 34 12.67 5.17 
35 38 11.69 4.77 
33 38 12.37 5.05 
32 39 11.15 4.55 
35 37 11.36 4.64 
33 32 9.95 4.06 
33 33 10.74 4.38 
36 35 6.03 2.46 
28 31 6.14 2.51 
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POMS 
CF§ TSCQRE§ 
Tension De1:1ressn Anger Vigour Fatigue Qonfusion 
Subject 1 37 41 45 52 61 59 
Subject 2 37 44 47 40 64 25 
Subject 3 49 60 52 30 73 57 
Subject4 49 37 56 33 67 53 
SubjectS 45 39 42 49 58 37 
Subject 6 63 42 41 32 64 77. 
Mean 46.7 43.8 47.2 39.3 64.5 50.5 
SD 9.7 8.3 5.8 9.3 5.2 16.8 
Control T SCORES 
Tension Oegressn Anger Vigour Fatigue Confusioa 
Subject 1 37 44 45 73 43 35 
Subject 2 31 37 37 65 34 37 
Subject 3 40 38 40 66 45 43 
Subject 4 42 44 41 59 35 41 
Subject 5 34 41 48 51 40 39 
Subject 6 33 39 41 65 34 32 
Mean 36.2 40.5 42.0 63.2 38.5 37.8 
so 4.3 3.0 3.9 7.4 4.8 4.0 
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